, Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the, Am J Respir Crit Care Med, vol.159, pp.1-40, 1999.

W. J. Evans, J. E. Morley, J. Argilés, C. Bales, V. Baracos et al., Cachexia: a new definition, Clin Nutr, vol.27, pp.793-799, 2008.

N. S. Hopkinson, R. C. Tennant, M. J. Dayer, E. B. Swallow, T. T. Hansel et al., A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease, Respir Res, vol.8, p.25, 2007.

B. Van-den-borst, A. Koster, B. Yu, H. R. Gosker, B. Meibohm et al., Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?, Thorax, vol.66, pp.961-969, 2011.

R. E. Burke, Revisiting the notion of 'motor unit types, Prog Brain Res, vol.123, pp.167-175, 1999.

R. E. Burke, D. N. Levine, F. E. Zajac, and . Iii, Mammalian motor units: physiological-histochemical correlation in three types in cat gastrocnemius, Science, vol.174, pp.709-712, 1971.

R. E. Burke, Motor unit types of cat triceps surae muscle, J Physiol, vol.193, pp.141-160, 1967.

G. C. Sieck and Y. S. Prakash, Morphological adaptations of neuromuscular junctions depend on fiber type, Can J Appl Physiol, vol.22, pp.197-230, 1997.

R. E. Sica and A. J. Mccomas, Fast and slow twitch units in a human muscle, J Neurol Neurosurg Psychiatry, vol.34, pp.113-120, 1971.

B. Feinstein, B. Lindegard, E. Nyman, and G. Wohlfart, Morphologic studies of motor units in normal human muscles, Acta Anat (Basel), vol.23, pp.127-142, 1955.

R. A. Garnett, M. J. O'donovan, J. A. Stephens, and A. Taylor, Motor unit organization of human medial gastrocnemius, J Physiol, vol.287, pp.33-43, 1979.

P. Sant'ana, J. A. Ennion, S. Sargeant, A. J. Moorman, A. F. Goldspink et al., Comparison of the molecular, antigenic and ATPase determinants of fast myosin heavy chains in rat and human: a single-fibre study, Pflugers Arch, vol.435, pp.151-163, 1997.

E. Henneman, Relation between size of neurons and their susceptibility to discharge, Science, vol.126, pp.1345-1347, 1957.

H. S. Milner-brown, R. B. Stein, and R. Yemm, The orderly recruitment of human motor units during voluntary isometric contractions, J Physiol, vol.230, pp.359-370, 1973.

J. A. Stephens and T. P. Usherwood, The mechanical properties of human motor units with special reference to their fatiguability and recruitment threshold, Brain Res, vol.125, pp.91-97, 1977.

R. Yemm, The orderly recruitment of motor units of the masseter and temporal muscles during voluntary isometric contraction in man, J Physiol, vol.265, pp.163-174, 1977.

J. E. Desmedt and E. Godaux, Ballistic contractions in man: characteristic recruitment pattern of single motor units of the tibialis anterior muscle, J Physiol, vol.264, pp.673-693, 1977.

J. M. Wakeling, Motor units are recruited in a task-dependent fashion during locomotion, J Exp Biol, vol.207, pp.3883-3890, 2004.

S. Mori, Discharge patterns of soleus motor units with associated changes in force exerted by foot during quiet stance in man, J Neurophysiol, vol.36, pp.458-471, 1973.

T. M. Vieira, I. D. Loram, S. Muceli, R. Merletti, and D. Farina, Recruitment of motor units in the medial gastrocnemius muscle during human quiet standing: is recruitment intermittent? What triggers recruitment?, J Neurophysiol, vol.107, pp.666-676, 2012.

J. Lexell, Human aging, muscle mass, and fiber type composition, J Gerontol A Biol Sci Med Sci, vol.50, pp.11-16, 1995.

J. A. Faulkner, L. M. Larkin, D. R. Claflin, and S. V. Brooks, Age-related changes in the structure and function of skeletal muscles, Clin Exp Pharmacol Physiol, vol.34, pp.1091-1096, 2007.

B. Essén-gustavsson and O. Borges, Histochemical and metabolic characteristics of human skeletal muscle in relation to age, Acta Physiol Scand, vol.126, pp.107-114, 1986.

A. A. Vandervoort, Aging of the human neuromuscular system, Muscle Nerve, vol.25, pp.17-25, 2002.

M. T. Korhonen, A. Cristea, M. Alén, K. Häkkinen, S. Sipilä et al., Aging, muscle fiber type, and contractile function in sprint-trained athletes, J Appl Physiol, vol.101, pp.906-917, 1985.

M. C. Brown, R. L. Holland, and W. G. Hopkins, Motor nerve sprouting, Annu Rev Neurosci, vol.4, pp.17-42, 1981.

A. R. Luff, Age-associated changes in the innervation of muscle fibers and changes in the mechanical properties of motor units, Ann N Y Acad Sci, vol.854, pp.92-101, 1998.

B. W. Fling, C. A. Knight, and G. Kamen, Relationships between motor unit size and recruitment threshold in older adults: implications for size principle, Exp Brain Res, vol.197, pp.125-133, 2009.

E. R. Mulder, K. H. Gerrits, B. U. Kleine, J. Rittweger, D. Felsenberg et al., High-density surface EMG study on the time course of central nervous and peripheral neuromuscular changes during 8 weeks of bed rest with or without resistive vibration exercise, J Electromyogr Kinesiol, vol.19, pp.208-218, 2009.

C. Cescon and M. Gazzoni, Short term bed-rest reduces conduction velocity of individual motor units in leg muscles, J Electromyogr Kinesiol, vol.20, pp.860-867, 2010.

J. Duchateau and K. Hainaut, Electrical and mechanical changes in immobilized human muscle, J Appl Physiol, vol.62, pp.2168-2173, 1985.

J. Duchateau and K. Hainaut, Effects of immobilization on contractile properties, recruitment and firing rates of human motor units, J Physiol, vol.422, pp.55-65, 1990.

K. Seki, Y. Taniguchi, and M. Narusawa, Effects of joint immobilization on firing rate modulation of human motor units, J Physiol, vol.530, pp.507-519, 2001.

K. Seki, T. Kizuka, and H. Yamada, Reduction in maximal firing rate of motoneurons after 1-week immobilization of finger muscle in human subjects, J Electromyogr Kinesiol, vol.17, pp.113-120, 2007.

J. P. Folland and A. G. Williams, The adaptations to strength training : morphological and neurological contributions to increased strength, Sports Med, vol.37, pp.145-168, 2007.

L. Griffin and E. Cafarelli, Resistance training: cortical, spinal, and motor unit adaptations, Can J Appl Physiol, vol.30, pp.328-340, 2005.

W. J. Gonyea, Role of exercise in inducing increases in skeletal muscle fiber number, J Appl Physiol, vol.48, pp.421-426, 1980.

K. A. Edman, Double-hyperbolic force-velocity relation in frog muscle fibres, J Physiol, vol.404, pp.301-321, 1988.

R. M. Enoka, Muscle fatigue-from motor units to clinical symptoms, J Biomech, vol.45, pp.427-433, 2012.

S. Chamberlain and D. M. Lewis, Contractile characteristics and innervation ratio of rat soleus motor units, J Physiol, vol.412, pp.1-21, 1989.

H. E. Berg, L. Larsson, and P. A. Tesch, Lower limb skeletal muscle function after 6 wk of bed rest, J Appl Physiol, vol.82, pp.182-188, 1985.

G. C. Sieck and M. Fournier, Diaphragm motor unit recruitment during ventilatory and nonventilatory behaviors, J Appl Physiol, vol.66, pp.2539-2545, 1985.

M. W. Fryer and I. R. Neering, Actions of caffeine on fast-and slow-twitch muscles of the rat, J Physiol, vol.416, pp.435-454, 1989.

M. W. Fryer and D. G. Stephenson, Total and sarcoplasmic reticulum calcium contents of skinned fibres from rat skeletal muscle, J Physiol, vol.493, pp.357-370, 1996.

G. Salviati and P. Volpe, Ca21 release from sarcoplasmic reticulum of skinned fast-and slow-twitch muscle fibers, Am J Physiol, vol.254, pp.459-465, 1988.

O. Delbono and G. Meissner, Sarcoplasmic reticulum Ca21 release in rat slow-and fast-twitch muscles, J Membr Biol, vol.151, pp.123-130, 1996.

D. G. Ferguson and C. Franzini-armstrong, The Ca21 ATPase content of slow and fast twitch fibers of guinea pig, Muscle Nerve, vol.11, pp.561-570, 1988.

S. Schiaffino and C. Reggiani, Molecular diversity of myofibrillar proteins: gene regulation and functional significance, Physiol Rev, vol.76, pp.371-423, 1996.

B. Laszewski-williams, R. L. Ruff, and A. M. Gordon, Influence of fiber type and muscle source on Ca21 sensitivity of rat fibers, Am J Physiol, vol.256, pp.420-427, 1989.

Y. Mounier, X. Holy, and L. Stevens, Compared properties of the contractile system of skinned slow and fast rat muscle fibres, Pflugers Arch, vol.415, pp.136-141, 1989.

D. G. Stephenson and Q. G. Forrest, Different isometric force -[Ca21] relationships in slow and fast twitch skinned muscle fibres of the rat, Biochim Biophys Acta, vol.589, pp.358-362, 1980.

D. G. Stephenson and D. A. Williams, Calcium-activated force responses in fast-and slow-twitch skinned muscle fibres of the rat at different temperatures, J Physiol, vol.317, pp.281-302, 1981.

G. C. Sieck and Y. S. Prakash, Cross-bridge kinetics in respiratory muscles, Eur Respir J, vol.10, pp.2147-2158, 1997.

G. C. Sieck, Y. S. Han, Y. S. Prakash, and K. A. Jones, Cross-bridge cycling kinetics, actomyosin ATPase activity and myosin heavy chain isoforms in skeletal and smooth respiratory muscles, Comp Biochem Physiol B Biochem Mol Biol, vol.119, pp.435-450, 1998.

E. J. Jones, P. A. Bishop, A. K. Woods, and J. M. Green, Cross-sectional area and muscular strength: a brief review, Sports Med, vol.38, pp.987-994, 2008.

T. Fukunaga, M. Miyatani, M. Tachi, M. Kouzaki, Y. Kawakami et al., Muscle volume is a major determinant of joint torque in humans, Acta Physiol Scand, vol.172, pp.249-255, 2001.

M. Ikai and T. Fukunaga, Calculation of muscle strength per unit crosssectional area of human muscle by means of ultrasonic measurement, Int Z Angew Physiol, vol.26, pp.26-32, 1968.

B. M. Moss, P. E. Refsnes, A. Abildgaard, K. Nicolaysen, and J. Jensen, Effects of maximal effort strength training with different loads on dynamic strength, cross-sectional area, load-power and load-velocity relationships, Eur J Appl Physiol Occup Physiol, vol.75, pp.193-199, 1997.

R. H. Fitts, K. S. Mcdonald, and J. M. Schluter, The determinants of skeletal muscle force and power: their adaptability with changes in activity pattern, J Biomech, vol.24, pp.111-122, 1991.

L. Larsson and R. L. Moss, Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles, J Physiol, vol.472, pp.595-614, 1993.

J. J. Widrick, S. W. Trappe, C. A. Blaser, D. L. Costill, and R. H. Fitts, Isometric force and maximal shortening velocity of single muscle fibers from elite master runners, Am J Physiol, vol.271, pp.666-675, 1996.

R. Bottinelli, M. Canepari, M. A. Pellegrino, and C. Reggiani, Force-velocity properties of human skeletal muscle fibres: myosin heavy chain isoform and temperature dependence, J Physiol, vol.495, pp.573-586, 1996.

P. C. Geiger, M. J. Cody, R. L. Macken, and G. C. Sieck, Maximum specific force depends on myosin heavy chain content in rat diaphragm muscle fibers, J Appl Physiol, vol.89, pp.695-703, 1985.

L. Larsson, G. Grimby, and J. Karlsson, Muscle strength and speed of movement in relation to age and muscle morphology, J Appl Physiol, vol.46, pp.451-456, 1979.

I. Janssen, S. B. Heymsfield, Z. M. Wang, and R. Ross, Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr, J Appl Physiol, vol.89, pp.81-88, 1985.

W. J. Chodzko-zajko, D. N. Proctor, F. Singh, M. A. Minson, C. T. Nigg et al., American College of Sports Medicine position stand. Exercise and physical activity for older adults, Med Sci Sports Exerc, vol.41, pp.1510-1530, 2009.

J. Lexell, C. C. Taylor, and M. Sjöström, What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15-to 83-year-old men, J Neurol Sci, vol.84, pp.275-294, 1988.

P. Aagaard, P. S. Magnusson, B. Larsson, M. Kjaer, and P. Krustrup, Mechanical muscle function, morphology, and fiber type in lifelong trained elderly, Med Sci Sports Exerc, vol.39, pp.1989-1996, 2007.

C. J. Caspersen, A. M. Kriska, and S. R. Dearwater, Physical activity epidemiology as applied to elderly populations, Baillieres Clin Rheumatol, vol.8, pp.7-27, 1994.

E. J. Bassey, M. J. Bendall, and M. Pearson, Muscle strength in the triceps surae and objectively measured customary walking activity in men and women over 65 years of age, Clin Sci (Lond), vol.74, pp.85-89, 1988.

H. J. Martin, H. E. Syddall, E. M. Dennison, C. Cooper, and A. A. Sayer, Relationship between customary physical activity, muscle strength and physical performance in older men and women: findings from the Hertfordshire Cohort Study, Age Ageing, vol.37, pp.589-593, 2008.

F. Ichas, L. S. Jouaville, and J. P. Mazat, Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals, Cell, vol.89, pp.1145-1153, 1997.

M. Murgia, C. Giorgi, P. Pinton, and R. Rizzuto, Controlling metabolism and cell death: at the heart of mitochondrial calcium signalling, J Mol Cell Cardiol, vol.46, pp.781-788, 2009.

P. Bernardi, Mitochondrial transport of cations: channels, exchangers, and permeability transition, Physiol Rev, vol.79, pp.1127-1155, 1999.

D. C. Wallace and F. W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion, vol.10, pp.12-31, 2010.

J. F. Turrens, Mitochondrial formation of reactive oxygen species, J Physiol, vol.552, pp.335-344, 2003.

J. J. Poderoso, A. Boveris, and E. Cadenas, Mitochondrial oxidative stress: a self-propagating process with implications for signaling cascades, Biofactors, vol.11, pp.43-45, 2000.

M. T. Crow, K. Mani, Y. J. Nam, and R. N. Kitsis, The mitochondrial death pathway and cardiac myocyte apoptosis, Circ Res, vol.95, pp.957-970, 2004.

M. P. Mattson and G. Kroemer, Mitochondria in cell death: novel targets for neuroprotection and cardioprotection, Trends Mol Med, vol.9, pp.196-205, 2003.

M. Zoratti and I. Szabò, The mitochondrial permeability transition, Biochim Biophys Acta, vol.1241, pp.139-176, 1995.

B. Saltin and L. B. Rowell, Functional adaptations to physical activity and inactivity, Fed Proc, vol.39, pp.1506-1513, 1980.

H. Reichmann, H. Hoppeler, O. Mathieu-costello, V. Bergen, F. Pette et al., Biochemical and ultrastructural changes of skeletal muscle mitochondria after chronic electrical stimulation in rabbits, Pflugers Arch, vol.404, pp.1-9, 1985.

S. Dimauro, A history of mitochondrial diseases, J Inherit Metab Dis, vol.34, pp.261-276, 2011.

D. C. Wallace, A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine, Annu Rev Genet, vol.39, pp.359-407, 2005.

J. A. Neder, P. W. Jones, L. E. Nery, and B. J. Whipp, Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship, Am J Respir Crit Care Med, vol.162, pp.497-504, 2000.

D. C. Poole, S. A. Ward, G. W. Gardner, and B. J. Whipp, Metabolic and respiratory profile of the upper limit for prolonged exercise in man, Ergonomics, vol.31, pp.1265-1279, 1988.

D. C. Poole, S. A. Ward, and B. J. Whipp, The effects of training on the metabolic and respiratory profile of high-intensity cycle ergometer exercise, Eur J Appl Physiol Occup Physiol, vol.59, pp.421-429, 1990.

Y. M. Luo, N. Hart, N. Mustfa, R. A. Lyall, M. I. Polkey et al., Effect of diaphragm fatigue on neural respiratory drive, J Appl Physiol, vol.90, pp.1691-1699, 1985.

E. Asmussen, Muscle fatigue, Med Sci Sports, vol.11, pp.313-321, 1979.

T. Fujimoto and H. Nishizono, Involvement of membrane excitation failure in fatigue induced by intermittent submaximal voluntary contraction of the first dorsal interosseous muscle, J Sports Med Phys Fitness, vol.33, pp.107-117, 1993.

H. Westerblad and D. G. Allen, Recent advances in the understanding of skeletal muscle fatigue, Curr Opin Rheumatol, vol.14, pp.648-652, 2002.

H. Westerblad and D. G. Allen, Cellular mechanisms of skeletal muscle fatigue, Adv Exp Med Biol, vol.538, pp.563-570, 2003.

R. H. Edwards, D. K. Hill, D. A. Jones, and P. A. Merton, Fatigue of long duration in human skeletal muscle after exercise, J Physiol, vol.272, pp.769-778, 1977.

J. Moxham, R. H. Edwards, M. Aubier, D. Troyer, A. Farkas et al., Changes in EMG power spectrum (high-to-low ratio) with force fatigue in humans, J Appl Physiol, vol.53, pp.1094-1099, 1982.

M. Amann and J. A. Dempsey, Locomotor muscle fatigue modifies central motor drive in healthy humans and imposes a limitation to exercise performance, J Physiol, vol.586, pp.161-173, 2008.

J. A. Timmons, T. Gustafsson, C. J. Sundberg, E. Jansson, E. Hultman et al., Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise, J Clin Invest, vol.101, pp.79-85, 1998.

P. L. Greenhaff and J. A. Timmons, Interaction between aerobic and anaerobic metabolism during intense muscle contraction, Exerc Sport Sci Rev, vol.26, pp.1-30, 1998.

C. T. Putman, L. L. Spriet, E. Hultman, D. J. Dyck, and G. J. Heigenhauser, Skeletal muscle pyruvate dehydrogenase activity during acetate infusion in humans, Am J Physiol, vol.268, pp.1007-1017, 1995.

B. Ludvik, G. Mayer, S. Stifter, D. Putz, U. Barnas et al., Effects of dichloroacetate on exercise performance in healthy volunteers, Pflugers Arch, vol.423, pp.251-254, 1993.

D. Constantin-teodosiu and P. L. Greenhaff, The tricarboxylic acid cycle in human skeletal muscle: is there a role for nutritional intervention?, Curr Opin Clin Nutr Metab Care, vol.2, pp.527-531, 1999.

G. Eliason, S. Abdel-halim, B. Arvidsson, and F. Kadi, Piehl-Aulin K. Physical performance and muscular characteristics in different stages of COPD, Scand J Med Sci Sports, vol.19, pp.865-870, 2009.

P. J. Plant, D. Brooks, M. Faughnan, T. Bayley, J. Bain et al., Cellular markers of muscle atrophy in chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol, vol.42, pp.461-471, 2010.

M. E. Thériault, M. E. Paré, F. Maltais, and R. Debigaré, Satellite cells senescence in limb muscle of severe patients with COPD, PLoS ONE, vol.7, p.39124, 2012.

W. E. Mitch and A. L. Goldberg, Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway, N Engl J Med, vol.335, pp.1897-1905, 1996.

J. L. Bailey, X. Wang, B. K. England, S. R. Price, X. Ding et al., The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway, J Clin Invest, vol.97, pp.1447-1453, 1996.

P. O. Hasselgren and J. E. Fischer, Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation, Ann Surg, vol.233, pp.9-17, 2001.

W. E. Mitch, J. L. Bailey, X. Wang, C. Jurkovitz, D. Newby et al., Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting, Am J Physiol, vol.276, pp.1132-1138, 1999.

Y. P. Li and M. B. Reid, NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes, Am J Physiol, vol.279, pp.1165-1170, 2000.

S. C. Bodine, E. Latres, S. Baumhueter, V. K. Lai, L. Nunez et al., Identification of ubiquitin ligases required for skeletal muscle atrophy, Science, vol.294, pp.1704-1708, 2001.

M. D. Gomes, S. H. Lecker, R. T. Jagoe, A. Navon, and A. L. Goldberg, Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy, Proc Natl Acad Sci, vol.98, pp.14440-14445, 2001.

V. Solomon and A. L. Goldberg, Importance of the ATP-ubiquitinproteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts, J Biol Chem, vol.271, pp.26690-26697, 1996.

I. J. Smith, S. H. Lecker, and P. O. Hasselgren, Calpain activity and muscle wasting in sepsis, Am J Physiol Endocrinol Metab, vol.295, pp.762-771, 2008.

J. Zhao, J. J. Brault, A. Schild, P. Cao, M. Sandri et al., FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells, Cell Metab, vol.6, pp.472-483, 2007.

J. Du, X. Wang, C. Miereles, J. L. Bailey, R. Debigaré et al., Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions, J Clin Invest, vol.113, pp.115-123, 2004.

J. M. Mcclung, A. R. Judge, S. K. Powers, and Z. Yan, p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting, Am J Physiol Cell Physiol, vol.298, pp.542-549, 2010.

D. J. Glass, Skeletal muscle hypertrophy and atrophy signaling pathways, Int J Biochem Cell Biol, vol.37, pp.1974-1984, 2005.

C. Mammucari, G. Milan, V. Romanello, E. Masiero, R. R. et al., FoxO3 controls autophagy in skeletal muscle in vivo, Cell Metab, vol.6, pp.458-471, 2007.

M. Sandri, C. Sandri, A. Gilbert, C. Skurk, E. Calabria et al., Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy, Cell, vol.117, pp.399-412, 2004.

D. Cai, J. D. Frantz, N. E. Tawa, P. A. Melendez, B. C. Oh et al., IKKbeta/ NF-kappaB activation causes severe muscle wasting in mice, Cell, vol.119, pp.285-298, 2004.

Y. P. Li, Y. Chen, J. John, J. Moylan, J. B. Mann et al., TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle, FASEB J, vol.19, pp.362-370, 2005.

T. L. Hilder, J. C. Tou, R. E. Grindeland, C. E. Wade, and L. M. Graves, Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle, FEBS Lett, vol.553, pp.63-67, 2003.

G. S. Supinski, X. Ji, and L. A. Callahan, The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation, Am J Physiol Regul Integr Comp Physiol, vol.297, pp.825-834, 2009.

A. U. Trendelenburg, A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama et al., Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size, Am J Physiol Cell Physiol, vol.296, pp.1258-1270, 2009.

M. R. Morissette, S. A. Cook, C. Buranasombati, M. A. Rosenberg, and A. Rosenzweig, Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt, Am J Physiol Cell Physiol, vol.297, pp.1124-1132, 2009.

S. Lokireddy, I. W. Wijesoma, S. K. Sze, C. Mcfarlane, R. Kambadur et al., Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting, Am J Physiol Cell Physiol, vol.303, pp.512-529, 2012.

S. Lokireddy, C. Mcfarlane, X. Ge, H. Zhang, S. K. Sze et al., Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting, Mol Endocrinol, vol.25, pp.1936-1949, 2011.

H. H. Vandenburgh, P. Karlisch, J. Shansky, and R. Feldstein, Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture, Am J Physiol, vol.260, pp.475-484, 1991.

C. Rommel, S. C. Bodine, B. A. Clarke, R. Rossman, L. Nunez et al., Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways, Stat Bull Metrop Life Found, vol.3, pp.3-9, 1983.

G. G. Harrison, Height-weight tables, Ann Intern Med, vol.103, pp.989-994, 1985.

J. Vestbo, E. Prescott, T. Almdal, M. Dahl, B. G. Nordestgaard et al., Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study, Am J Respir Crit Care Med, vol.173, pp.79-83, 2006.

A. M. Schols, R. Broekhuizen, C. A. Weling-scheepers, and E. F. Wouters, Body composition and mortality in chronic obstructive pulmonary disease, Am J Clin Nutr, vol.82, pp.53-59, 2005.

Y. Schutz, U. U. Kyle, and C. Pichard, Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98, Int J Obes Relat Metab Disord, vol.26, pp.953-960, 2002.

A. M. Schols, P. B. Soeters, A. M. Dingemans, R. Mostert, P. J. Frantzen et al., Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation, Am Rev Respir Dis, vol.147, pp.1151-1156, 1993.

C. Coronell, M. Orozco-levi, and J. Gea, COPD and body weight in a Mediterranean population, Clin Nutr, vol.21, pp.437-438, 2002.

M. P. Engelen, A. M. Schols, J. D. Does, and E. F. Wouters, Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease, Am J Clin Nutr, vol.71, pp.733-738, 2000.

M. A. Caron, R. Debigaré, P. N. Dekhuijzen, and F. Maltais, Comparative assessment of the quadriceps and the diaphragm in patients with COPD, J Appl Physiol, vol.107, pp.952-961, 1985.

S. Bernard, P. Leblanc, F. Whittom, G. Carrier, J. Jobin et al., Peripheral muscle weakness in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.158, pp.629-634, 1998.

M. D. Eisner, P. D. Blanc, S. Sidney, E. H. Yelin, P. V. Lathon et al., Body composition and functional limitation in COPD, Respir Res, vol.8, p.7, 2007.

L. M. Steuten, E. C. Creutzberg, H. J. Vrijhoef, and E. F. Wouters, COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care, Prim Care Respir J, vol.15, pp.84-91, 2006.

S. Guerra, D. L. Sherrill, A. Bobadilla, F. D. Martinez, and R. A. Barbee, The relation of body mass index to asthma, chronic bronchitis, and emphysema, Chest, vol.122, pp.1256-1263, 2002.

F. M. Franssen, O. De, G. H. Goossens, E. E. Blaak, and A. M. Schols, Obesity and the lung: 5. Obesity and COPD, Thorax, vol.63, pp.1110-1117, 2008.

P. Mancuso, Obesity and lung inflammation, J Appl Physiol, vol.108, pp.722-728, 1985.

E. P. Rutten, M. K. Breyer, M. A. Spruit, T. Hofstra, P. P. Van-melick et al., Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease, Clin Nutr, vol.29, pp.756-760, 2010.

P. Skyba, J. Ukropec, P. Pobeha, B. Ukropcova, P. Joppa et al., Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease, Mediators Inflamm, p.173498, 2010.

B. Van-den-borst, H. R. Gosker, G. Wesseling, W. De-jager, V. A. Hellwig et al., Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease, Am J Clin Nutr, vol.94, pp.1504-1512, 2011.

K. Marquis, F. Maltais, V. Duguay, A. M. Bezeau, P. Leblanc et al., The metabolic syndrome in patients with chronic obstructive pulmonary disease, J Cardiopulm Rehabil, vol.25, pp.233-234, 2005.

K. B. Lam, R. E. Jordan, C. Q. Jiang, G. N. Thomas, M. R. Miller et al., Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study, Eur Respir J, vol.35, pp.317-323, 2010.

A. M. Schols, J. Slangen, L. Volovics, and E. F. Wouters, Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.157, pp.1791-1797, 1998.

C. Landbo, E. Prescott, P. Lange, J. Vestbo, and T. P. Almdal, Prognostic value of nutritional status in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.160, pp.1856-1861, 1999.

M. Poulain, M. Doucet, V. Drapeau, G. Fournier, A. Tremblay et al., Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease, Chron Respir Dis, vol.5, pp.35-41, 2008.

B. Van-den-borst, H. R. Gosker, A. Koster, B. Yu, S. B. Kritchevsky et al., Aging, and Body Composition (Health ABC) Study. The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease, Am J Clin Nutr, vol.96, pp.516-526, 2012.

G. T. Ferguson, P. M. Calverley, J. A. Anderson, C. R. Jenkins, P. W. Jones et al., Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study, Chest, vol.136, pp.1456-1465, 2009.

L. Graat-verboom, E. F. Wouters, F. W. Smeenk, . Van-den-borne, . Be et al., Current status of research on osteoporosis in COPD: a systematic review, Eur Respir J, vol.34, pp.209-218, 2009.

D. R. Silva, A. C. Coelho, A. Dumke, J. D. Valentini, J. N. De-nunes et al., Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study, Respir Care, vol.56, pp.961-968, 2011.

A. Coin, G. Sergi, S. Marin, A. Vianello, E. Perissinotto et al., Predictors of low bone mineral density in elderly males with chronic obstructive pulmonary disease: the role of body mass index, Aging Male, vol.13, pp.142-147, 2010.

C. E. Bolton, A. A. Ionescu, K. M. Shiels, R. J. Pettit, P. H. Edwards et al., Associated loss of fatfree mass and bone mineral density in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.170, pp.1286-1293, 2004.

M. P. Engelen, A. M. Schols, R. J. Lamers, and E. F. Wouters, Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease, Clin Nutr, vol.18, pp.275-280, 1999.

H. Kurosaki, T. Ishii, N. Motohashi, T. Motegi, K. Yamada et al., Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD, Intern Med, vol.48, pp.41-48, 2009.

E. P. Rutten, T. B. Grydeland, S. G. Pillai, S. Wagers, A. Dirksen et al., Quantitative CT: associations between emphysema, airway wall thickness and body composition in COPD, Pulm Med, p.419328, 2011.

H. R. Gosker, M. P. Zeegers, E. F. Wouters, and A. M. Schols, Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis, Thorax, vol.62, pp.944-949, 2007.

H. C. Kim, M. Mofarrahi, and S. N. Hussain, Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease, Int J Chron Obstruct Pulmon Dis, vol.3, pp.637-658, 2008.

F. Whittom, J. Jobin, P. M. Simard, P. Leblanc, C. Simard et al., Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease, Med Sci Sports Exerc, vol.30, pp.1467-1474, 1998.

J. Jobin, F. Maltais, J. F. Doyon, P. Leblanc, P. M. Simard et al., Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle, J Cardiopulm Rehabil, vol.18, pp.432-437, 1998.

I. Vogiatzis, G. Terzis, G. Stratakos, E. Cherouveim, D. Athanasopoulos et al., Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV, Chest, vol.140, pp.744-752, 2011.

L. Larsson, Histochemical characteristics of human skeletal muscle during aging, Acta Physiol Scand, vol.117, pp.469-471, 1983.

M. Doucet, R. Debigaré, D. R. Joanisse, C. Côté, P. Leblanc et al., Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD, Eur Respir J, vol.24, pp.971-979, 2004.

J. G. Gea, M. Pasto, M. A. Carmona, M. Orozco-levi, J. Palomeque et al., Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease, Eur Respir J, vol.17, pp.939-945, 2001.

H. R. Gosker, M. P. Engelen, H. Van-mameren, P. J. Van-dijk, G. J. Van-der-vusse et al., Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease, Am J Clin Nutr, vol.76, pp.113-119, 2002.

S. A. Natanek, J. Riddoch-contreras, G. S. Marsh, N. S. Hopkinson, W. D. Man et al., Yin Yang 1 expression and localisation in quadriceps muscle in COPD, Arch Bronconeumol, vol.47, pp.296-302, 2011.

C. Fermoselle, R. Rabinovich, P. Ausín, E. Puig-vilanova, C. Coronell et al., Does oxidative stress modulate limb muscle atrophy in severe COPD patients?, Eur Respir J, vol.40, pp.851-862, 2012.

R. S. Richardson, B. T. Leek, T. P. Gavin, L. J. Haseler, S. R. Mudaliar et al., Reduced mechanical efficiency in chronic obstructive pulmonary disease but normal peak VO2 with small muscle mass exercise, Am J Respir Crit Care Med, vol.169, pp.89-96, 2004.

R. A. Rabinovich and J. Vilaró, Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients, Curr Opin Pulm Med, vol.16, pp.123-133, 2010.

G. Eliason, S. M. Abdel-halim, K. Piehl-aulin, and F. Kadi, Alterations in the muscle-to-capillary interface in patients with different degrees of chronic obstructive pulmonary disease, Respir Res, vol.11, p.97, 2010.

H. R. Gosker, M. K. Hesselink, H. Duimel, K. A. Ward, and A. M. Schols, Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD, Eur Respir J, vol.30, pp.73-79, 2007.

L. Puente-maestu, J. Pérez-parra, R. Godoy, N. Moreno, A. Tejedor et al., Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients, Eur Respir J, vol.33, pp.1045-1052, 2009.

F. Maltais, P. Leblanc, F. Whittom, C. Simard, K. Marquis et al., Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD, Thorax, vol.55, pp.848-853, 2000.

H. J. Green, E. Bombardier, M. Burnett, S. Iqbal, D. 'arsigny et al., Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease, Am J Physiol Regul Integr Comp Physiol, vol.295, pp.935-941, 2008.

M. Picard, R. Godin, M. Sinnreich, J. Baril, J. Bourbeau et al., The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction?, Am J Respir Crit Care Med, vol.178, pp.1040-1047, 2008.

A. H. Remels, P. Schrauwen, R. Broekhuizen, J. Willems, S. Kersten et al., Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD, Eur Respir J, vol.30, pp.245-252, 2007.

R. A. Rabinovich, R. Bastos, E. Ardite, L. Llinàs, M. Orozco-levi et al., Mitochondrial dysfunction in COPD patients with low body mass index, Eur Respir J, vol.29, pp.643-650, 2007.

L. Puente-maestu, J. Pérez-parra, R. Godoy, N. Moreno, A. Tejedor et al., Abnormal transition pore kinetics and cytochrome C release in muscle mitochondria of patients with chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol, vol.40, pp.746-750, 2009.

A. I. Naimi, J. Bourbeau, H. Perrault, J. Baril, C. Wright-paradis et al., Altered mitochondrial regulation in quadriceps muscles of patients with COPD, Clin Physiol Funct Imaging, vol.31, pp.124-131, 2011.

H. R. Gosker, P. Schrauwen, M. K. Hesselink, G. Schaart, G. J. Van-der-vusse et al., Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD, Eur Respir J, vol.22, pp.88-93, 2003.

A. P. Russell, E. Somm, R. Debigaré, O. Hartley, D. Richard et al., COPD results in a reduction in UCP3 long mRNA and UCP3 protein content in types I and IIa skeletal muscle fibers, J Cardiopulm Rehabil, vol.24, pp.332-339, 2004.

J. Sauleda, F. García-palmer, R. J. Wiesner, S. Tarraga, I. Harting et al., Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.157, pp.1413-1417, 1998.

M. Picard, K. Csukly, M. E. Robillard, R. Godin, A. Ascah et al., Resistance to Ca21-induced opening of the permeability transition pore differs in mitochondria from glycolytic and oxidative muscles, Am J Physiol Regul Integr Comp Physiol, vol.295, pp.659-668, 2008.

E. J. Anderson and P. D. Neufer, Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation, Am J Physiol Cell Physiol, vol.290, pp.844-851, 2006.

A. G. Agustí, J. Sauleda, C. Miralles, C. Gomez, B. Togores et al., Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.166, pp.485-489, 2002.

F. Maltais, A. A. Simard, C. Simard, J. Jobin, P. Desgagnés et al., Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD, Am J Respir Crit Care Med, vol.153, pp.288-293, 1996.

F. Maltais, D. Saey, and R. Debigaré, Enhancing the benefits of pulmonary rehabilitation: doing more for a few or doing a little less for many?, Am J Respir Crit Care Med, vol.178, pp.215-216, 2008.

E. Sala, J. Roca, R. M. Marrades, J. Alonso, G. De-suso et al., Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.159, pp.1726-1734, 1999.

J. Vilaro, R. Rabinovich, J. M. Gonzalez-desuso, T. Troosters, D. Rodríguez et al., Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease, Am J Phys Med Rehabil, vol.88, pp.39-46, 2009.

R. Debigaré, C. H. Côté, and F. Maltais, Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms, Am J Respir Crit Care Med, vol.164, pp.1712-1717, 2001.

H. J. Green, M. E. Burnett, D. 'arsigny, C. L. , O. De et al., Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease, J Appl Physiol, vol.105, pp.879-886, 1985.

D. Saey, B. B. Lemire, P. Gagnon, E. Bombardier, A. R. Tupling et al., Quadriceps metabolism during constant workrate cycling exercise in chronic obstructive pulmonary disease, J Appl Physiol, vol.110, pp.116-124, 1985.

E. Fiaccadori, D. Canale, S. Vitali, P. Coffrini, E. Ronda et al., Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia, Chest, vol.92, pp.883-887, 1987.

H. J. Green, E. Bombardier, T. A. Duhamel, R. D. Stewart, A. R. Tupling et al., Metabolic, enzymatic, and transporter responses in human muscle during three consecutive days of exercise and recovery, Am J Physiol Regul Integr Comp Physiol, vol.295, pp.1238-1250, 2008.

P. Jakobsson, L. Jorfeldt, and J. Henriksson, Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.151, pp.374-377, 1995.

N. Turan, S. Kalko, A. Stincone, K. Clarke, A. Sabah et al., A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease, PLOS Comput Biol, vol.7, p.1002129, 2011.

E. Barreiro, R. Rabinovich, J. Marin-corral, J. A. Barberà, J. Gea et al., Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD, Thorax, vol.64, pp.13-19, 2009.

D. A. Rodriguez, G. Alcarraz-vizán, S. Diaz-moralli, M. Reed, F. P. Gomez et al., Plasma metabolic profile in COPD patients: effects of exercise and endurance training, Metabolomics, vol.8, pp.508-516, 2012.

R. S. Richardson, J. Sheldon, D. C. Poole, S. R. Hopkins, A. L. Ries et al., Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.159, pp.881-885, 1999.

G. Layec, L. J. Haseler, J. Hoff, and R. S. Richardson, Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings, Am J Physiol Regul Integr Comp Physiol, vol.300, pp.1142-1147, 2011.

A. M. Schols, E. W. Fredrix, P. B. Soeters, K. R. Westerterp, and E. F. Wouters, Resting energy expenditure in patients with chronic obstructive pulmonary disease, Am J Clin Nutr, vol.54, pp.983-987, 1991.

E. M. Baarends, A. M. Schols, K. R. Westerterp, and E. F. Wouters, Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD, Thorax, vol.52, pp.780-785, 1997.

C. C. Kao, J. W. Hsu, V. Bandi, N. A. Hanania, F. Kheradmand et al., Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease, Metabolism, vol.60, pp.1449-1455, 2011.

V. Cavalheri, L. Donária, T. Ferreira, M. Finatti, C. A. Camillo et al., Energy expenditure during daily activities as measured by two motion sensors in patients with COPD, Respir Med, vol.105, pp.922-929, 2011.

M. B. Reid, Invited Review: redox modulation of skeletal muscle contraction: what we know and what we don't, J Appl Physiol, vol.90, pp.724-731, 1985.

D. Javeshghani, S. A. Magder, E. Barreiro, M. T. Quinn, and S. N. Hussain, Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles, Am J Respir Crit Care Med, vol.165, pp.412-418, 2002.

M. J. Jackson, D. Pye, and J. Palomero, The production of reactive oxygen and nitrogen species by skeletal muscle, J Appl Physiol, vol.102, pp.1664-1670, 1985.

S. K. Powers, A. N. Kavazis, and K. C. Deruisseau, Mechanisms of disuse muscle atrophy: role of oxidative stress, Am J Physiol Regul Integr Comp Physiol, vol.288, pp.337-344, 2005.

G. Supinski, Free radical induced respiratory muscle dysfunction, Mol Cell Biochem, vol.179, pp.99-110, 1998.

J. S. Stamler and G. Meissner, Physiology of nitric oxide in skeletal muscle, Physiol Rev, vol.81, pp.209-237, 2001.

J. S. Beckman and W. H. Koppenol, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly, Am J Physiol, vol.271, pp.1424-1437, 1996.

J. De-batlle, E. Barreiro, I. Romieu, M. Mendez, F. P. Gómez et al., Dietary modulation of oxidative stress in chronic obstructive pulmonary disease patients, Free Radic Res, vol.44, pp.1296-1303, 2010.

D. A. Rodriguez, S. Kalko, E. Puig-vilanova, M. Perez-olabarría, F. Falciani et al., Muscle and blood redox status after exercise training in severe COPD patients, Free Radic Biol Med, vol.52, pp.88-94, 2012.

F. Ribera, N. 'guessan, B. Zoll, J. Fortin, D. Serrurier et al., Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.167, pp.873-879, 2003.

J. Allaire, F. Maltais, P. Leblanc, P. M. Simard, F. Whittom et al., Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary disease, Muscle Nerve, vol.25, pp.383-389, 2002.

E. Barreiro, J. Gea, J. M. Corominas, and S. N. Hussain, Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol, vol.29, pp.771-778, 2003.

E. Barreiro, B. De-la-puente, J. Minguella, J. M. Corominas, S. Serrano et al., Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.171, pp.1116-1124, 2005.

E. Barreiro, J. Gea, G. Matar, and S. N. Hussain, Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease, Am J Respir Cell Mol Biol, vol.33, pp.636-642, 2005.

E. Barreiro, A. M. Schols, M. I. Polkey, J. B. Galdiz, H. R. Gosker et al., ENIGMA in COPD project. Cytokine profile in quadriceps muscles of patients with severe COPD, Thorax, vol.63, pp.100-107, 2008.

A. Couillard, F. Maltais, D. Saey, R. Debigaré, A. Michaud et al., Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.167, pp.1664-1669, 2003.

M. P. Engelen, A. M. Schols, J. D. Does, N. E. Deutz, and E. F. Wouters, Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema, Am J Respir Crit Care Med, vol.161, pp.98-103, 2000.

L. M. Heunks, J. Viña, C. L. Van-herwaarden, H. T. Folgering, A. Gimeno et al., Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease, Am J Physiol, vol.277, pp.1697-1704, 1999.

C. Koechlin, A. Couillard, D. Simar, J. P. Cristol, H. Bellet et al., Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?, Am J Respir Crit Care Med, vol.169, pp.1022-1027, 2004.

C. Koechlin, A. Couillard, J. P. Cristol, P. Chanez, M. Hayot et al., Does systemic inflammation trigger local exerciseinduced oxidative stress in COPD?, Eur Respir J, vol.23, pp.538-544, 2004.

C. Koechlin, F. Maltais, D. Saey, A. Michaud, P. Leblanc et al., Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease, Thorax, vol.60, pp.834-841, 2005.

J. Marin-corral, J. Minguella, A. L. Ramírez-sarmiento, S. N. Hussain, J. Gea et al., Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients, Eur Respir J, vol.33, pp.1309-1319, 2009.

R. A. Rabinovich, E. Ardite, T. Troosters, N. Carbó, J. Alonso et al., Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.164, pp.1114-1118, 2001.

H. A. Van-helvoort, Y. F. Heijdra, H. M. Thijs, J. Viña, G. J. Wanten et al., Exercise-induced systemic effects in muscle-wasted patients with COPD, Med Sci Sports Exerc, vol.38, pp.1543-1552, 2006.

E. Barreiro, V. I. Peinado, J. B. Galdiz, E. Ferrer, J. Marin-corral et al., ENIGMA in COPD Project. Cigarette smokeinduced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction, Am J Respir Crit Care Med, vol.182, pp.477-488, 2010.

E. Barreiro, L. Del-puerto-nevado, E. Puig-vilanova, S. Pérez-rial, F. Sánchez et al., Cigarette smoke-induced oxidative stress in skeletal muscles of mice, Respir Physiol Neurobiol, vol.182, pp.9-17, 2012.

L. Puente-maestu, T. Tena, C. Trascasa, J. Pérez-parra, R. Godoy et al., Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease, Eur J Appl Physiol, vol.88, pp.580-587, 2003.

E. Barreiro, D. Ferrer, F. Sanchez, J. Minguella, J. Marin-corral et al., Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD, J Appl Physiol, vol.111, pp.808-817, 1985.

C. J. Clark, L. M. Cochrane, E. Mackay, and B. Paton, Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training, Eur Respir J, vol.15, pp.92-97, 2000.

R. Gosselink, T. Troosters, and M. Decramer, Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease, J Cardiopulm Rehabil, vol.20, pp.353-360, 2000.

R. Debigaré, C. H. Côte, F. S. Hould, P. Leblanc, and F. Maltais, In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD, Eur Respir J, vol.21, pp.273-278, 2003.

M. J. Mador, E. Bozkanat, and T. J. Kufel, Quadriceps fatigue after cycle exercise in patients with COPD compared with healthy control subjects, Chest, vol.123, pp.1104-1111, 2003.

M. A. Spruit, R. Gosselink, T. Troosters, A. Kasran, G. Gayan-ramirez et al., Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I, Thorax, vol.58, pp.752-756, 2003.

J. Allaire, F. Maltais, J. F. Doyon, M. Noël, P. Leblanc et al., Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD, Thorax, vol.59, pp.673-678, 2004.

C. Coronell, M. Orozco-levi, R. Méndez, A. Ramírez-sarmiento, J. B. Gáldiz et al., Relevance of assessing quadriceps endurance in patients with COPD, Eur Respir J, vol.24, pp.129-136, 2004.

F. M. Franssen, R. Broekhuizen, P. P. Janssen, E. F. Wouters, and A. M. Schols, Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training, Med Sci Sports Exerc, vol.37, pp.2-9, 2005.

W. D. Man, N. S. Hopkinson, F. Harraf, D. Nikoletou, M. I. Polkey et al., Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease, Thorax, vol.60, pp.718-722, 2005.

I. Vivodtzev, P. Flore, P. Lévy, and B. Wuyam, Voluntary activation during knee extensions in severely deconditioned patients with chronic obstructive pulmonary disease: benefit of endurance training, Muscle Nerve, vol.37, pp.27-35, 2008.

J. M. Seymour, K. Ward, P. S. Sidhu, Z. Puthucheary, J. Steier et al., Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD, Thorax, vol.64, pp.418-423, 2009.

J. M. Seymour, M. A. Spruit, N. S. Hopkinson, S. A. Natanek, W. D. Man et al., The prevalence of quadriceps weakness in COPD and the relationship with disease severity, Eur Respir J, vol.36, pp.81-88, 2010.

W. D. Man, M. G. Soliman, D. Nikoletou, M. L. Harris, G. F. Rafferty et al., Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease, Thorax, vol.58, pp.665-669, 2003.

W. D. Man, M. G. Soliman, J. Gearing, S. G. Radford, G. F. Rafferty et al., Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.168, pp.562-567, 2003.

M. Decramer, L. M. Lacquet, R. Fagard, and P. Rogiers, Corticosteroids contribute to muscle weakness in chronic airflow obstruction, Am J Respir Crit Care Med, vol.150, pp.11-16, 1994.

N. S. Hopkinson, W. D. Man, M. J. Dayer, E. T. Ross, A. H. Nickol et al., Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease, Eur Respir J, vol.24, pp.137-142, 2004.

Y. F. Heijdra, V. Pinto-plata, R. Frants, J. Rassulo, L. Kenney et al., Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects, Chest, vol.124, pp.75-82, 2003.

A. Couillard, C. Koechlin, J. P. Cristol, A. Varray, and C. Préfaut, Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients, Eur Respir J, vol.20, pp.1123-1129, 2002.
URL : https://hal.archives-ouvertes.fr/hal-01622943

T. Janaudis-ferreira, K. Wadell, G. Sundelin, and B. Lindström, Thigh muscle strength and endurance in patients with COPD compared with healthy controls, Respir Med, vol.100, pp.1451-1457, 2006.

I. Serres, V. Gautier, A. Varray, and C. Préfaut, Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients, Chest, vol.113, pp.900-905, 1998.
URL : https://hal.archives-ouvertes.fr/hal-01625242

A. Van't-hul, J. Harlaar, R. Gosselink, P. Hollander, P. Postmus et al., Quadriceps muscle endurance in patients with chronic obstructive pulmonary disease, Muscle Nerve, vol.29, pp.267-274, 2004.

E. B. Swallow, H. R. Gosker, K. A. Ward, A. J. Moore, M. J. Dayer et al., A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans, J Appl Physiol, vol.103, pp.739-746, 1985.

F. Gouzi, C. Préfaut, A. Abdellaoui, A. Vuillemin, N. Molinari et al., Evidence of an early physical activity reduction in chronic obstructive pulmonary disease patients, Arch Phys Med Rehabil, vol.92, pp.1611-1617, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01623976

B. Van-den-borst, I. G. Slot, V. A. Hellwig, B. A. Vosse, M. C. Kelders et al., Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-tomoderate COPD, J Appl Physiol, vol.114, pp.1319-1328, 2013.

S. Z. Newell, D. K. Mckenzie, and S. C. Gandevia, Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation, Thorax, vol.44, pp.903-912, 1989.

M. C. Zattara-hartmann, M. Badier, C. Guillot, C. Tomei, and Y. Jammes, Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing, Muscle Nerve, vol.18, pp.495-502, 1995.

K. J. Killian, P. Leblanc, D. H. Martin, E. Summers, N. L. Jones et al., Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation, Am Rev Respir Dis, vol.146, pp.935-940, 1992.

S. J. Butcher, O. Lagerquist, D. D. Marciniuk, S. R. Petersen, D. F. Collins et al., Relationship between ventilatory constraint and muscle fatigue during exercise in COPD, Eur Respir J, vol.33, pp.763-770, 2009.

M. J. Mador, T. J. Kufel, L. A. Pineda, A. Steinwald, A. Aggarwal et al., Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise, Am J Respir Crit Care Med, vol.163, pp.930-935, 2001.

D. Saey, R. Debigaré, P. Leblanc, M. J. Mador, C. H. Côté et al., Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.168, pp.425-430, 2003.

M. Amann, M. S. Regan, M. Kobitary, M. W. Eldridge, U. Boutellier et al., Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD, Am J Physiol Regul Integr Comp Physiol, vol.299, pp.314-324, 2010.

M. I. Polkey, D. Kyroussis, C. H. Hamnegard, G. H. Mills, M. Green et al., Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man, Muscle Nerve, vol.19, pp.549-555, 1996.

D. Saey, C. H. Côté, M. J. Mador, L. Laviolette, P. Leblanc et al., Assessment of muscle fatigue during exercise in chronic obstructive pulmonary disease, Muscle Nerve, vol.34, pp.62-71, 2006.

V. Pepin, D. Saey, F. Whittom, P. Leblanc, and F. Maltais, Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.172, pp.1517-1522, 2005.

N. Marquis, R. Debigaré, L. Bouyer, D. Saey, L. Laviolette et al., Physiology of walking in patients with moderate to severe chronic obstructive pulmonary disease, Med Sci Sports Exerc, vol.41, pp.1540-1548, 2009.

P. Gagnon, F. Maltais, L. Bouyer, F. Ribeiro, V. Coats et al., Distal leg muscle function in patients with COPD, COPD, vol.10, pp.235-242, 2013.

F. Pitta, T. Troosters, V. S. Probst, M. A. Spruit, M. Decramer et al., Physical activity and hospitalization for exacerbation of COPD, Chest, vol.129, pp.536-544, 2006.

T. Crul, M. A. Spruit, G. Gayan-ramirez, R. Quarck, R. Gosselink et al., Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients, Eur J Clin Invest, vol.37, pp.897-904, 2007.

J. Vilaró, A. Ramirez-sarmiento, J. M. Martínez-llorens, T. Mendoza, M. Alvarez et al., Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations, Respir Med, vol.104, pp.1896-1902, 2010.

T. Crul, D. Testelmans, M. A. Spruit, T. Troosters, R. Gosselink et al., Gene expression profiling in vastus lateralis muscle during an acute exacerbation of COPD, Cell Physiol Biochem, vol.25, pp.491-500, 2010.

M. A. Vermeeren, A. M. Schols, and E. F. Wouters, Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD, Eur Respir J, vol.10, pp.2264-2269, 1997.

M. A. Vermeeren, E. F. Wouters, A. J. Geraerts-keeris, and A. M. Schols, Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation

, Clin Nutr, vol.23, pp.1184-1192, 2004.

G. C. Donaldson, T. M. Wilkinson, J. R. Hurst, W. R. Perera, and J. A. Wedzicha, Exacerbations and time spent outdoors in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.171, pp.446-452, 2005.

K. Marquis, R. Debigaré, Y. Lacasse, P. Leblanc, J. Jobin et al., Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.166, pp.809-813, 2002.

A. M. Schols, E. F. Wouters, P. B. Soeters, and K. R. Westerterp, Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease, Am J Clin Nutr, vol.53, pp.421-424, 1991.

E. B. Swallow, D. Reyes, N. S. Hopkinson, W. D. Man, R. Porcher et al., Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease, Thorax, vol.62, pp.115-120, 2007.

N. L. Jones and K. J. Killian, Limitation of exercise in chronic airway obstruction, pp.196-206, 1991.

R. Gosselink, T. Troosters, and M. Decramer, Peripheral muscle weakness contributes to exercise limitation in COPD, Am J Respir Crit Care Med, vol.153, pp.976-980, 1996.

A. L. Hamilton, K. J. Killian, E. Summers, and N. L. Jones, Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders, Am J Respir Crit Care Med, vol.152, pp.2021-2031, 1995.

T. J. Williams, G. A. Patterson, P. A. Mcclean, N. Zamel, and J. R. Maurer, Maximal exercise testing in single and double lung transplant recipients, Am Rev Respir Dis, vol.145, pp.101-105, 1992.

D. Deschênes, V. Pepin, D. Saey, P. Leblanc, and F. Maltais, Locus of symptom limitation and exercise response to bronchodilation in chronic obstructive pulmonary disease, J Cardiopulm Rehabil Prev, vol.28, pp.208-214, 2008.

R. Casaburi, A. Patessio, F. Ioli, S. Zanaboni, C. F. Donner et al., Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease, Am Rev Respir Dis, vol.143, pp.9-18, 1991.

F. Maltais, S. Bernard, J. Jobin, R. Belleau, and P. Leblanc, Lactate kinetics during exercise in chronic obstructive pulmonary disease, Can Respir J, vol.4, pp.251-257, 1997.

F. Maltais, J. Jobin, M. J. Sullivan, S. Bernard, F. Whittom et al., Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD, J Appl Physiol, vol.84, pp.1573-1580, 1985.

M. C. Steiner, R. Evans, S. J. Deacon, S. J. Singh, P. Patel et al., Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease, Thorax, vol.60, pp.932-936, 2005.

L. D. Calvert, S. J. Singh, P. L. Greenhaff, M. D. Morgan, and M. C. Steiner, The plasma ammonia response to cycle exercise in COPD, Eur Respir J, vol.31, pp.751-758, 2008.

L. D. Calvert, R. Shelley, S. J. Singh, P. L. Greenhaff, J. Bankart et al., Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.177, pp.1090-1094, 2008.

M. Amann, L. T. Proctor, J. J. Sebranek, D. F. Pegelow, and J. A. Dempsey, Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans, J Physiol, vol.587, pp.271-283, 2009.

P. Gagnon, J. S. Bussières, F. Ribeiro, S. L. Gagnon, D. Saey et al., Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.186, pp.606-615, 2012.

M. Amann, L. T. Proctor, J. J. Sebranek, M. W. Eldridge, D. F. Pegelow et al., Somatosensory feedback from the limbs exerts inhibitory influences on central neural drive during whole body endurance exercise, J Appl Physiol, vol.105, pp.1714-1724, 1985.

T. D. Noakes, A. St-clair-gibson, and E. V. Lambert, From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans: summary and conclusions, Br J Sports Med, vol.39, pp.120-124, 2005.

P. Gagnon, D. Saey, I. Vivodtzev, L. Laviolette, V. Mainguy et al., Impact of preinduced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects, J Appl Physiol, vol.107, pp.832-840, 1985.

C. Burtin, D. Saey, M. Saglam, D. Langer, R. Gosselink et al., Effectiveness of exercise training in patients with COPD: the role of muscle fatigue, Eur Respir J, vol.40, pp.338-344, 2012.

R. Mostert, A. Goris, C. Weling-scheepers, E. F. Wouters, and A. M. Schols, Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease, Respir Med, vol.94, pp.859-867, 2000.

M. Decramer, R. Gosselink, T. Troosters, M. Verschueren, and G. Evers, Muscle weakness is related to utilization of health care resources in COPD patients, Eur Respir J, vol.10, pp.417-423, 1997.

L. Bossenbroek, M. H. De-greef, J. B. Wempe, and W. P. Krijnen, Ten Hacken NH. Daily physical activity in patients with chronic obstructive pulmonary disease: a systematic review, COPD, vol.8, pp.306-319, 2011.

F. W. Booth and P. D. Gollnick, Effects of disuse on the structure and function of skeletal muscle, Med Sci Sports Exerc, vol.15, pp.415-420, 1983.

L. Larsson and T. Ansved, Effects of long-term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristic in man, Muscle Nerve, vol.8, pp.714-722, 1985.

E. F. Coyle, W. H. Martin, . Iii, S. A. Bloomfield, O. H. Lowry et al., Effects of detraining on responses to submaximal exercise, J Appl Physiol, vol.59, pp.853-859, 1985.

R. Casaburi and . Deconditioning, Pulmonary rehabilitation, pp.213-230, 1996.

M. I. Polkey and J. Moxham, Attacking the disease spiral in chronic obstructive pulmonary disease, Clin Med, vol.6, pp.190-196, 2006.

A. Couillard and C. Préfaut, From muscle disuse to myopathy in COPD: potential contribution of oxidative stress, Eur Respir J, vol.26, pp.703-719, 2005.

M. I. Polkey and K. F. Rabe, Chicken or egg: physical activity in COPD revisited, Eur Respir J, vol.33, pp.227-229, 2009.

M. I. Polkey and J. Moxham, Attacking the disease spiral in chronic obstructive pulmonary disease: an update, Clin Med, vol.11, pp.461-464, 2011.

P. D. Wagner, Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy?, Respirology, vol.11, pp.681-686, 2006.

E. Brønstad, O. Rognmo, A. E. Tjonna, H. H. Dedichen, I. Kirkeby-garstad et al., High-intensity knee extensor training restores skeletal muscle function in COPD patients, Eur Respir J, vol.40, pp.1130-1136, 2012.

W. D. Man, P. Kemp, J. Moxham, and M. I. Polkey, Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation, Clin Sci (Lond), vol.117, pp.281-291, 2009.

T. Troosters, R. Gosselink, and M. Decramer, Short-and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial, Am J Med, vol.109, pp.207-212, 2000.

H. R. Gosker, P. Schrauwen, R. Broekhuizen, M. K. Hesselink, E. Moonen-kornips et al., Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease, Am J Physiol Endocrinol Metab, vol.290, pp.976-981, 2006.

M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz et al., Skeletal muscle adaptations to testosterone and resistance training in men with COPD, J Appl Physiol, vol.103, pp.1299-1310, 1985.

H. Howald, H. Hoppeler, H. Claassen, O. Mathieu, and R. Straub, Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans, Pflugers Arch, vol.403, pp.369-376, 1985.

A. P. Russell, J. Feilchenfeldt, S. Schreiber, M. Praz, A. Crettenand et al., Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle, Diabetes, vol.52, pp.2874-2881, 2003.

J. A. Simoneau, G. Lortie, M. R. Boulay, M. Marcotte, M. C. Thibault et al., Human skeletal muscle fiber type alteration with highintensity intermittent training, Eur J Appl Physiol Occup Physiol, vol.54, pp.250-253, 1985.

H. R. Middlekauff, Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure, Circ Heart Fail, vol.3, pp.537-546, 2010.

T. A. Rehn, M. Munkvik, P. K. Lunde, I. Sjaastad, and O. M. Sejersted, Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?, Heart Fail Rev, vol.17, pp.421-436, 2012.

U. Späte and P. C. Schulze, Proinflammatory cytokines and skeletal muscle, Curr Opin Clin Nutr Metab Care, vol.7, pp.265-269, 2004.

P. M. Siu, Muscle apoptotic response to denervation, disuse, and aging, Med Sci Sports Exerc, vol.41, pp.1876-1886, 2009.

J. Harris, Autophagy and cytokines, Cytokine, vol.56, pp.140-144, 2011.

M. Doucet, A. P. Russell, B. Léger, R. Debigaré, D. R. Joanisse et al., Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.176, pp.261-269, 2007.

A. Koncarevic, R. W. Jackman, and S. C. Kandarian, The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension, FASEB J, vol.21, pp.427-437, 2007.

E. Vasyutina, D. C. Lenhard, and C. Birchmeier, Notch function in myogenesis, Cell Cycle, vol.6, pp.1451-1454, 2007.

J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. Wilkinson, J. A. Bilello et al., Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.174, pp.867-874, 2006.

F. Karadag, A. B. Karul, O. Cildag, M. Yilmaz, and H. Ozcan, Biomarkers of systemic inflammation in stable and exacerbation phases of COPD, Lung, vol.186, pp.403-409, 2008.

N. Takabatake, H. Nakamura, S. Abe, S. Inoue, T. Hino et al., The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.161, pp.1179-1184, 2000.

M. Montes-de-oca, S. H. Torres, D. Sanctis, J. Mata, A. Hernández et al., Skeletal muscle inflammation and nitric oxide in patients with COPD, Eur Respir J, vol.26, pp.390-397, 2005.

H. R. Gosker, B. Kubat, G. Schaart, G. J. Van-der-vusse, E. F. Wouters et al., Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease, Eur Respir J, vol.22, pp.280-285, 2003.

R. Debigaré, F. Maltais, C. H. Côté, A. Michaud, M. A. Caron et al., Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting, COPD, vol.5, pp.75-84, 2008.

R. A. Rabinovich, M. Figueras, E. Ardite, N. Carbó, T. Troosters et al., Increased tumour necrosis factor-alpha plasma levels during moderateintensity exercise in COPD patients, Eur Respir J, vol.21, pp.789-794, 2003.

A. Agustí, M. Morlá, J. Sauleda, C. Saus, and X. Busquets, NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight, Thorax, vol.59, pp.483-487, 2004.

J. S. Moylan and M. B. Reid, Oxidative stress, chronic disease, and muscle wasting, Muscle Nerve, vol.35, pp.411-429, 2007.

I. Stanojkovic, J. Kotur-stevuljevic, B. Milenkovic, S. Spasic, T. Vujic et al., Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation, Respir Med, vol.105, pp.31-37, 2011.

Y. P. Li, Y. Chen, A. S. Li, and M. B. Reid, Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes, Am J Physiol Cell Physiol, vol.285, pp.806-812, 2003.

Y. P. Li, R. J. Schwartz, I. D. Waddell, B. R. Holloway, and M. B. Reid, Skeletal muscle myocytes undergo protein loss and reactive oxygenmediated NF-kappaB activation in response to tumor necrosis factor alpha, FASEB J, vol.12, pp.871-880, 1998.

M. Buck and M. Chojkier, Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants, EMBO J, vol.15, pp.1753-1765, 1996.

Y. Furukawa-hibi, Y. Kobayashi, C. Chen, and N. Motoyama, FOXO transcription factors in cell-cycle regulation and the response to oxidative stress, Antioxid Redox Signal, vol.7, pp.752-760, 2005.

B. B. Lemire, R. Debigaré, A. Dubé, M. E. Thériault, C. H. Côté et al., MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease, J Appl Physiol, vol.113, pp.159-166, 1985.

J. Magalhães, A. Ascensão, J. M. Soares, R. Ferreira, M. J. Neuparth et al., Acute and chronic exposition of mice to severe hypoxia: the role of acclimatization against skeletal muscle oxidative stress, Int J Sports Med, vol.26, pp.102-109, 2005.

H. Hoppeler, E. Kleinert, C. Schlegel, H. Claassen, H. Howald et al., Morphological adaptations of human skeletal muscle to chronic hypoxia, Int J Sports Med, vol.11, pp.3-9, 1990.

Z. Yun, Q. Lin, and A. J. Giaccia, Adaptive myogenesis under hypoxia, Mol Cell Biol, vol.25, pp.3040-3055, 2005.

G. Pitsiou, G. Kyriazis, O. Hatzizisi, P. Argyropoulou, E. Mavrofridis et al., Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease, Respir Med, vol.96, pp.594-598, 2002.

G. L. Semenza, Regulation of oxygen homeostasis by hypoxia-inducible factor 1, Physiology (Bethesda), vol.24, pp.97-106, 2009.

K. Jatta, G. Eliason, G. M. Portela-gomes, L. Grimelius, O. Caro et al., Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease, J Clin Pathol, vol.62, pp.70-76, 2009.

F. B. Favier, F. Costes, A. Defour, R. Bonnefoy, E. Lefai et al., Downregulation of Akt/ mammalian target of rapamycin pathway in skeletal muscle is associated with increased REDD1 expression in response to chronic hypoxia, Am J Physiol Regul Integr Comp Physiol, vol.298, pp.1659-1666, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00593929

M. A. Caron, M. E. Thériault, M. E. Paré, F. Maltais, and R. Debigaré, Hypoxia alters contractile protein homeostasis in L6 myotubes, FEBS Lett, vol.583, pp.1528-1534, 2009.

P. D. Wagner, The biology of oxygen, Eur Respir J, vol.31, pp.887-890, 2008.

I. Vogiatzis, D. Athanasopoulos, H. Habazettl, A. Aliverti, Z. Louvaris et al., Intercostal muscle blood flow limitation during exercise in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.182, pp.1105-1113, 2010.

L. Puente-maestu, A. Lázaro, A. Tejedor, S. Camaño, M. Fuentes et al., Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD, Thorax, vol.66, pp.121-127, 2011.

N. S. Chandel, D. S. Mcclintock, C. E. Feliciano, T. M. Wood, J. A. Melendez et al., Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O 2 sensing, J Biol Chem, vol.275, pp.25130-25138, 2000.

J. M. Hare, Nitric oxide and excitation-contraction coupling, J Mol Cell Cardiol, vol.35, pp.719-729, 2003.

D. J. Singel and J. S. Stamler, Blood traffic control, Nature, vol.430, p.297, 2004.

J. M. Hare, Nitroso-redox balance in the cardiovascular system, N Engl J Med, vol.351, pp.2112-2114, 2004.

N. C. Gonzalez and J. G. Wood, Alveolar hypoxia-induced systemic inflammation: what low PO( 2 ) does and does not do, Adv Exp Med Biol, vol.662, pp.27-32, 2010.

C. De-theije, F. Costes, R. C. Langen, C. Pison, and H. R. Gosker, Hypoxia and muscle maintenance regulation: implications for chronic respiratory disease, Curr Opin Clin Nutr Metab Care, vol.14, pp.548-553, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00696292

J. F. Payen, B. Wuyam, P. Levy, H. Reutenauer, P. Stieglitz et al., Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia, Am Rev Respir Dis, vol.147, pp.592-598, 1993.

B. Wuyam, J. F. Payen, P. Levy, H. Bensaïdane, H. Reutenauer et al., Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease, Eur Respir J, vol.5, pp.157-162, 1992.

B. K. England, J. L. Chastain, and W. E. Mitch, Abnormalities in protein synthesis and degradation induced by extracellular pH in BC3H1 myocytes, Am J Physiol, vol.260, pp.277-282, 1991.

H. A. Franch, S. Raissi, X. Wang, B. Zheng, J. L. Bailey et al., Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis, Am J Physiol Renal Physiol, vol.287, pp.700-706, 2004.

T. N. Stitt, D. Drujan, B. A. Clarke, F. Panaro, Y. Timofeyva et al., The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors, Mol Cell, vol.14, pp.395-403, 2004.

M. Van-vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van-herck et al., Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.172, pp.1105-1111, 2005.

A. Kamischke, D. E. Kemper, M. A. Castel, M. Lüthke, C. Rolf et al., Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy, Eur Respir J, vol.11, pp.41-45, 1998.

F. Karadag, H. Ozcan, A. B. Karul, M. Yilmaz, and O. Cildag, Sex hormone alterations and systemic inflammation in chronic obstructive pulmonary disease, Int J Clin Pract, vol.63, pp.275-281, 2009.

F. Laghi, W. E. Langbein, A. Antonescu-turcu, A. Jubran, C. Bammert et al., Respiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.171, pp.598-605, 2005.

R. Debigaré, K. Marquis, C. H. Côté, R. R. Tremblay, A. Michaud et al., Catabolic/anabolic balance and muscle wasting in patients with COPD, Chest, vol.124, pp.83-89, 2003.

S. Bhasin, G. R. Cunningham, F. J. Hayes, A. M. Matsumoto, P. J. Snyder et al., Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, vol.95, pp.2536-2559, 2010.

C. P. Velloso, Regulation of muscle mass by growth hormone and IGF-I, Br J Pharmacol, vol.154, pp.557-568, 2008.

S. Bhasin, T. W. Storer, N. Berman, C. Callegari, B. Clevenger et al., The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men, N Engl J Med, vol.335, pp.1-7, 1996.

S. J. Lee, Regulation of muscle mass by myostatin, Annu Rev Cell Dev Biol, vol.20, pp.61-86, 2004.

B. Elliott, D. Renshaw, S. Getting, and R. Mackenzie, The central role of myostatin in skeletal muscle and whole body homeostasis, Acta Physiol (Oxf), vol.205, pp.324-340, 2012.

S. M. Roth and S. Walsh, Myostatin: a therapeutic target for skeletal muscle wasting, Curr Opin Clin Nutr Metab Care, vol.7, pp.259-263, 2004.

W. D. Man, S. A. Natanek, J. Riddoch-contreras, A. Lewis, G. S. Marsh et al., Quadriceps myostatin expression in COPD, Eur Respir J, vol.36, pp.686-688, 2010.

M. Hayot, J. Rodriguez, B. Vernus, G. Carnac, J. E. Allen et al., Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli, Mol Cell Endocrinol, vol.332, pp.38-47, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00654970

C. R. Ju and R. C. Chen, Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease, Respir Med, vol.106, pp.102-108, 2012.

T. Troosters, V. S. Probst, T. Crul, F. Pitta, G. Gayan-ramirez et al., Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.181, pp.1072-1077, 2010.

A. M. Schols, P. B. Soeters, R. Mostert, W. H. Saris, and E. F. Wouters, Energy balance in chronic obstructive pulmonary disease, Am Rev Respir Dis, vol.143, pp.1248-1252, 1991.

A. H. Goris, M. A. Vermeeren, E. F. Wouters, A. M. Schols, and K. R. Westerterp, Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: the effect of physical activity and oral nutritional supplementation, Br J Nutr, vol.89, pp.725-731, 2003.

D. A. King, F. Cordova, and S. M. Scharf, Nutritional aspects of chronic obstructive pulmonary disease, Proc Am Thorac Soc, vol.5, pp.519-523, 2008.

A. H. Remels, H. R. Gosker, R. C. Langen, and A. M. Schols, The mechanisms of cachexia underlying muscle dysfunction in COPD, J Appl Physiol, vol.114, pp.1253-1262, 2013.

M. Decramer, V. De-bock, and D. R. , Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.153, pp.1958-1964, 1996.

O. Schakman, H. Gilson, S. Kalista, and J. P. Thissen, Mechanisms of muscle atrophy induced by glucocorticoids, Horm Res, vol.72, pp.36-41, 2009.

B. Hamilton, Vitamin D and human skeletal muscle, Scand J Med Sci Sports, vol.20, pp.182-190, 2010.

A. J. Dirks-naylor and S. Lennon-edwards, The effects of vitamin D on skeletal muscle function and cellular signaling, J Steroid Biochem Mol Biol, vol.125, pp.159-168, 2011.

H. A. Bischoff-ferrari, T. Dietrich, E. J. Orav, F. B. Hu, Y. Zhang et al., Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged . or =60, Am J Clin Nutr, vol.80, pp.752-758, 2004.

L. Ceglia, Vitamin D and its role in skeletal muscle, Curr Opin Clin Nutr Metab Care, vol.12, pp.628-633, 2009.

J. C. Menant, J. C. Close, K. Delbaere, D. L. Sturnieks, J. Trollor et al., Relationships between serum vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women, Osteoporos Int, vol.23, pp.981-989, 2012.

I. S. Wicherts, N. M. Van-schoor, A. J. Boeke, M. Visser, D. J. Deeg et al., Vitamin D status predicts physical performance and its decline in older persons, J Clin Endocrinol Metab, vol.92, pp.2058-2065, 2007.

R. Boland, Role of vitamin D in skeletal muscle function, Endocr Rev, vol.7, pp.434-448, 1986.

S. Yoshikawa, T. Nakamura, H. Tanabe, and T. Imamura, Osteomalacic myopathy, Endocrinol Jpn, vol.26, pp.65-72, 1979.

O. H. Sørensen, B. Lund, B. Saltin, B. Lund, R. B. Andersen et al., Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium, Clin Sci (Lond), vol.56, pp.157-161, 1979.

Y. Sato, J. Iwamoto, T. Kanoko, and K. Satoh, Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial, Cerebrovasc Dis, vol.20, pp.187-192, 2005.

R. Boland, A. R. De-boland, E. Ritz, and W. Hasselbach, Effect of 1,25-dihydroxycholecalciferol on sarcoplasmic reticulum calcium transport in strontium-fed chicks, Calcif Tissue Int, vol.35, pp.190-194, 1983.

R. Boland, A. R. De-boland, M. J. Marinissen, G. Santillan, G. Vazquez et al., Avian muscle cells as targets for the secosteroid hormone 1,25-dihydroxy-vitamin D3, Mol Cell Endocrinol, vol.114, pp.1-8, 1995.

L. Drittanti, A. R. De-boland, and R. Boland, Stimulation of calmodulin synthesis in proliferating myoblasts by 1,25-dihydroxy-vitamin D3, Mol Cell Endocrinol, vol.74, pp.143-153, 1990.

J. J. Pointon, M. J. Francis, and R. Smith, Effect of vitamin D deficiency on sarcoplasmic reticulum function and troponin C concentration of rabbit skeletal muscle, Clin Sci (Lond), vol.57, pp.257-263, 1979.

W. Janssens, A. Lehouck, C. Carremans, R. Bouillon, C. Mathieu et al., Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act, Am J Respir Crit Care Med, vol.179, pp.630-636, 2009.

C. F. Vogelmeier and E. F. Wouters, Treating the systemic effects of chronic obstructive pulmonary disease, Proc Am Thorac Soc, vol.8, pp.376-379, 2011.

W. Janssens, R. Bouillon, B. Claes, C. Carremans, A. Lehouck et al., Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene, Thorax, vol.65, pp.215-220, 2010.

H. A. Bischoff-ferrari, E. J. Orav, and B. Dawson-hughes, Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial, Arch Intern Med, vol.166, pp.424-430, 2006.

A. S. Jackson, D. Shrikrishna, J. L. Kelly, N. Hart, J. Moxham et al., Vitamin D and skeletal muscle strength and endurance in COPD, Eur Respir J, vol.41, pp.309-316, 2013.

N. S. Hopkinson, K. W. Li, A. Kehoe, S. E. Humphries, M. Roughton et al., Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease, Am J Clin Nutr, vol.87, pp.385-390, 2008.

D. Shrikrishna, R. Astin, P. R. Kemp, and N. S. Hopkinson, Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease, Clin Sci (Lond), vol.123, pp.487-498, 2012.

Y. H. Song, Y. Li, J. Du, W. E. Mitch, N. Rosenthal et al., Musclespecific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting, J Clin Invest, vol.115, pp.451-458, 2005.

S. T. Russell, S. M. Wyke, and M. J. Tisdale, Mechanism of induction of muscle protein degradation by angiotensin II, Cell Signal, vol.18, pp.1087-1096, 2006.

R. D. Cohn, C. Van-erp, J. P. Habashi, A. A. Soleimani, E. C. Klein et al., Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states, Nat Med, vol.13, pp.204-210, 2007.

A. H. Danser, M. A. Schalekamp, W. A. Bax, A. M. Van-den-brink, P. R. Saxena et al., Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism, Circulation, vol.92, pp.1387-1388, 1995.

A. G. Williams, M. P. Rayson, M. Jubb, M. World, D. R. Woods et al., The ACE gene and muscle performance, Nature, vol.403, p.614, 2000.

S. Myerson, H. Hemingway, R. Budget, J. Martin, S. Humphries et al., Human angiotensin I-converting enzyme gene and endurance performance, J Appl Physiol, vol.87, pp.1313-1316, 1985.

B. Zhang, H. Tanaka, N. Shono, S. Miura, A. Kiyonaga et al., The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle, Clin Genet, vol.63, pp.139-144, 2003.

N. S. Hopkinson, A. H. Nickol, J. Payne, E. Hawe, W. D. Man et al., Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.170, pp.395-399, 2004.

J. Folland, B. Leach, T. Little, K. Hawker, S. Myerson et al., Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload, Exp Physiol, vol.85, pp.575-579, 2000.

B. De-paepe, G. G. Brusselle, T. Maes, K. K. Creus, D. 'hose et al., TNF alpha receptor genotype influences smoking-induced muscle-fibre-type shift and atrophy in mice, Acta Neuropathol, vol.115, pp.675-681, 2008.

H. R. Gosker, R. C. Langen, K. R. Bracke, G. F. Joos, G. G. Brusselle et al., Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure, Am J Respir Cell Mol Biol, vol.40, pp.710-716, 2009.

K. Tang, P. D. Wagner, and E. C. Breen, TNF-alpha-mediated reduction in PGC-1alpha may impair skeletal muscle function after cigarette smoke exposure, J Cell Physiol, vol.222, pp.320-327, 2010.

M. Rinaldi, K. Maes, D. Vleeschauwer, S. Thomas, D. Verbeken et al., Long-term nose-only cigarette smoke exposure induces emphysema and mild skeletal muscle dysfunction in mice, Dis Model Mech, vol.5, pp.333-341, 2012.

M. Montes-de-oca, E. Loeb, S. H. Torres, D. Sanctis, J. Hernández et al., Peripheral muscle alterations in non-COPD smokers, Chest, vol.133, pp.13-18, 2008.

J. Orlander, K. H. Kiessling, and L. Larsson, Skeletal muscle metabolism, morphology and function in sedentary smokers and nonsmokers, Acta Physiol Scand, vol.107, pp.39-46, 1979.

L. Larsson and J. Orlander, Skeletal muscle morphology, metabolism and function in smokers and non-smokers. A study on smokingdiscordant monozygous twins, Acta Physiol Scand, vol.120, pp.343-352, 1984.

D. Saey, A. Michaud, A. Couillard, C. H. Côté, M. J. Mador et al., Contractile fatigue, muscle morphometry, and blood lactate in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.171, pp.1109-1115, 2005.

M. Amann, G. M. Blain, L. T. Proctor, J. J. Sebranek, D. F. Pegelow et al., Implications of group III and IV muscle afferents for highintensity endurance exercise performance in humans, J Physiol, vol.589, pp.5299-5309, 2011.

J. A. Dempsey, A. W. Sheel, C. M. St-croix, and B. J. Morgan, Respiratory influences on sympathetic vasomotor outflow in humans, Respir Physiol Neurobiol, vol.130, pp.3-20, 2002.

C. A. Harms, M. A. Babcock, S. R. Mcclaran, D. F. Pegelow, G. A. Nickele et al., Respiratory muscle work compromises leg blood flow during maximal exercise, J Appl Physiol, vol.82, pp.1573-1583, 1985.

L. M. Romer, A. T. Lovering, H. C. Haverkamp, D. F. Pegelow, and J. A. Dempsey, Effect of inspiratory muscle work on peripheral fatigue of locomotor muscles in healthy humans, J Physiol, vol.571, pp.425-439, 2006.

M. Simon, P. Leblanc, J. Jobin, M. Desmeules, M. J. Sullivan et al., Limitation of lower limb VO( 2 ) during cycling exercise in COPD patients, J Appl Physiol, vol.90, pp.1013-1019, 1985.

I. Vogiatzis, H. Habazettl, A. Aliverti, D. Athanasopoulos, Z. Louvaris et al., Effect of helium breathing on intercostal and quadriceps muscle blood flow during exercise in COPD patients, Am J Physiol Regul Integr Comp Physiol, vol.300, pp.1549-1559, 2011.

N. S. Hopkinson, M. J. Dayer, A. , S. Swallow, E. B. Porcher et al., Central and peripheral quadriceps fatigue in congestive heart failure, Int J Cardiol, vol.167, pp.2594-2599, 2013.

R. G. Barr, D. A. Bluemke, F. S. Ahmed, J. J. Carr, P. L. Enright et al., Percent emphysema, airflow obstruction, and impaired left ventricular filling, N Engl J Med, vol.362, pp.217-227, 2010.

S. Holverda, H. Rietema, N. Westerhof, J. T. Marcus, C. T. Gan et al., Vonk-Noordegraaf A. Stroke volume increase to exercise in chronic obstructive pulmonary disease is limited by increased pulmonary artery pressure, Heart, vol.95, pp.137-141, 2009.

J. M. Hilde, I. Skjørten, V. Hansteen, M. N. Melsom, J. Hisdal et al., Haemodynamic responses to exercise in patients with COPD, Eur Respir J, vol.41, pp.1031-1041, 2013.

I. Vogiatzis, D. C. Simoes, G. Stratakos, E. Kourepini, G. Terzis et al., Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD, Eur Respir J, vol.36, pp.301-310, 2010.

K. Sahlin, Muscle fatigue and lactic acid accumulation, Acta Physiol Scand Suppl, vol.556, pp.83-91, 1986.

K. Sahlin, Metabolic factors in fatigue, Sports Med, vol.13, pp.99-107, 1992.

K. Sahlin, M. Tonkonogi, and K. Söderlund, Energy supply and muscle fatigue in humans, Acta Physiol Scand, vol.162, pp.261-266, 1998.

K. Sahlin, K. Söderlund, M. Tonkonogi, and K. Hirakoba, Phosphocreatine content in single fibers of human muscle after sustained submaximal exercise, Am J Physiol, vol.273, pp.172-178, 1997.

G. W. Mainwood and J. M. Renaud, The effect of acid-base balance on fatigue of skeletal muscle, Can J Physiol Pharmacol, vol.63, pp.403-416, 1985.

R. H. Fitts, Cellular mechanisms of muscle fatigue, Physiol Rev, vol.74, pp.49-94, 1994.

P. G. Wilcox, J. M. Hards, K. Bockhold, B. Bressler, and R. L. Pardy, Pathologic changes and contractile properties of the diaphragm in corticosteroid myopathy in hamsters: comparison to peripheral muscle, Am J Respir Cell Mol Biol, vol.1, pp.191-199, 1989.

K. J. Tracey, S. F. Lowry, B. Beutler, A. Cerami, J. D. Albert et al., Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential, J Exp Med, vol.164, pp.1368-1373, 1986.

T. Kutsuzawa, S. Shioya, D. Kurita, M. Haida, Y. Ohta et al., 31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment, Am Rev Respir Dis, vol.146, pp.1019-1024, 1992.

P. Jakobsson, L. Jorfeldt, and A. Brundin, Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure, Eur Respir J, vol.3, pp.192-196, 1990.

I. L. Hildebrand, C. Sylvén, M. Esbjörnsson, K. Hellström, and E. Jansson, Does chronic hypoxaemia induce transformations of fibre types?, Acta Physiol Scand, vol.141, pp.435-439, 1991.

P. N. Dekhuijzen, K. K. Aben, I. Dekker, L. P. Aarts, P. L. Wielders et al., Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.154, pp.813-816, 1996.

M. C. Steiner, R. L. Barton, S. J. Singh, and M. D. Morgan, Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD, Eur Respir J, vol.19, pp.626-631, 2002.

H. C. Lukaski, P. E. Johnson, W. W. Bolonchuk, and G. I. Lykken, Assessment of fat-free mass using bioelectrical impedance measurements of the human body, Am J Clin Nutr, vol.41, pp.810-817, 1985.

E. P. Rutten, M. A. Spruit, and E. F. Wouters, Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD, Respir Med, vol.104, pp.91-98, 2010.

M. P. Engelen, A. M. Schols, G. A. Heidendal, and E. F. Wouters, Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease, Am J Clin Nutr, vol.68, pp.1298-1303, 1998.

M. C. Lerario, A. Sachs, M. Lazaretti-castro, L. G. Saraiva, and J. R. Jardim, Body composition in patients with chronic obstructive pulmonary disease: which method to use in clinical practice?, Br J Nutr, vol.96, pp.86-92, 2006.

S. Mathur, K. P. Takai, D. L. Macintyre, and D. Reid, Estimation of thigh muscle mass with magnetic resonance imaging in older adults and people with chronic obstructive pulmonary disease, Phys Ther, vol.88, pp.219-230, 2008.

B. Hajghanbari, G. Hamarneh, N. Changizi, A. D. Ward, and W. D. Reid, MRIbased 3D shape analysis of thigh muscles patients with chronic obstructive pulmonary disease versus healthy adults, Acad Radiol, vol.18, pp.155-166, 2011.

A. R. Coggan, Muscle biopsy as a tool in the study of aging, J Gerontol A Biol Sci Med Sci, vol.50, pp.30-34, 1995.

J. Bergström, Muscle electrolytes in man. Determination by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients and patients with chronic diarrhoea, Scand J Clin Lab Invest, vol.14, p.110, 1962.

J. Bergström, Percutaneous needle biopsy of skeletal muscle in physiological and clinical research, Scand J Clin Lab Invest, vol.35, pp.609-616, 1975.

M. A. Tarnopolsky, P. E. Smith, K. Lach, and B. , Suction-modified Bergström muscle biopsy technique: experience with 13,500 procedures, Muscle Nerve, vol.43, pp.717-725, 2011.

M. Hayot, A. Michaud, C. Koechlin, M. A. Caron, P. Leblanc et al., Skeletal muscle microbiopsy: a validation study of a minimally invasive technique, Eur Respir J, vol.25, pp.431-440, 2005.

C. R. Van-wetering, F. E. Van-nooten, S. J. Mol, M. Hoogendoorn, M. P. Rutten-van-mölken et al., Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial, Int J Chron Obstruct Pulmon Dis, vol.3, pp.443-451, 2008.

J. L. Kelly, S. L. Elkin, J. Fluxman, M. I. Polkey, M. A. Soljak et al., Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care, COPD, vol.10, pp.40-54, 2013.

P. G. Robles, S. Mathur, T. Janaudis-fereira, T. E. Dolmage, R. S. Goldstein et al., Measurement of peripheral muscle strength in individuals with chronic obstructive pulmonary disease: a systematic review, J Cardiopulm Rehabil Prev, vol.31, pp.11-24, 2011.

E. Zanotti, G. Felicetti, M. Maini, and C. Fracchia, Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation, Chest, vol.124, pp.292-296, 2003.

G. Hermans, B. Clerckx, T. Vanhullebusch, J. Segers, G. Vanpee et al., Interobserver agreement of Medical Research Council sumscore and handgrip strength in the intensive care unit, Muscle Nerve, vol.45, pp.18-25, 2012.

C. A. Stone, B. Nolan, P. G. Lawlor, and R. A. Kenny, Hand-held dynamometry: tester strength is paramount, even in frail populations, J Rehabil Med, vol.43, pp.808-811, 2011.

M. E. Kaelin, A. M. Swank, K. J. Adams, K. L. Barnard, J. M. Berning et al., Cardiopulmonary responses, muscle soreness, and injury during the one repetition maximum assessment in pulmonary rehabilitation patients, J Cardiopulm Rehabil, vol.19, pp.366-372, 1999.

R. Casaburi, S. Bhasin, L. Cosentino, J. Porszasz, A. Somfay et al., Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.170, pp.870-878, 2004.

M. J. Mador, E. Bozkanat, A. Aggarwal, M. Shaffer, and T. J. Kufel, Endurance and strength training in patients with COPD, Chest, vol.125, pp.2036-2045, 2004.

S. Mathur, L. Makrides, and P. Hernandez, Test-retest reliability of isometric and isokinetic torque in patients with chronic obstructive pulmonary disease, Physiother Can, vol.56, pp.94-101, 2004.

N. A. Maffiuletti, M. Bizzini, K. Desbrosses, N. Babault, and U. Munzinger, Reliability of knee extension and flexion measurements using the Con-Trex isokinetic dynamometer, Clin Physiol Funct Imaging, vol.27, pp.346-353, 2007.

C. Malaguti, L. M. Napolis, D. Villaça, J. A. Neder, L. E. Nery et al., Relationship between peripheral muscle structure and function in patients with chronic obstructive pulmonary disease with different nutritional status, J Strength Cond Res, vol.25, pp.1795-1803, 2011.

M. K. Beauchamp, K. M. Sibley, B. Lakhani, J. Romano, S. Mathur et al., Impairments in systems underlying control of balance in COPD, Chest, vol.141, pp.1496-1503, 2012.

L. Vieira, M. Bottaro, R. Celes, C. A. Viegas, and C. A. Silva, Isokinetic muscle evaluation of quadriceps in patients with chronic obstructive pulmonary disease, Rev Port Pneumol, vol.16, pp.717-736, 2010.

H. Degens, J. M. Sanchez-horneros, Y. F. Heijdra, P. N. Dekhuijzen, and M. T. Hopman, Skeletal muscle contractility is preserved in COPD patients with normal fat-free mass, Acta Physiol Scand, vol.184, pp.235-242, 2005.

C. R. Ju and R. C. Chen, Quadriceps strength assessed by magnetic stimulation of femoral nerve in patients with chronic obstructive pulmonary disease, Chin Med J (Engl), vol.124, pp.2309-2315, 2011.

T. J. Kufel, L. A. Pineda, and M. J. Mador, Comparison of potentiated and unpotentiated twitches as an index of muscle fatigue, Muscle Nerve, vol.25, pp.438-444, 2002.

K. Tomazin, S. Verges, N. Decorte, A. Oulerich, and G. Y. Millet, Effects of coil characteristics for femoral nerve magnetic stimulation, Muscle Nerve, vol.41, pp.406-409, 2010.

C. H. Hamnegård, M. Sedler, M. I. Polkey, and B. Bake, Quadriceps strength assessed by magnetic stimulation of the femoral nerve in normal subjects, Clin Physiol Funct Imaging, vol.24, pp.276-280, 2004.

N. S. Hopkinson, T. Sharshar, E. T. Ross, A. H. Nickol, M. J. Dayer et al., Corticospinal control of respiratory muscles in chronic obstructive pulmonary disease, Respir Physiol Neurobiol, vol.141, pp.1-12, 2004.

A. A. Mohamed-hussein, S. A. Hamed, A. , and N. , Cerebral cortical dysfunction in chronic obstructive pulmonary disease: role of transcranial magnetic stimulation, Int J Tuberc Lung Dis, vol.11, pp.515-521, 2007.

C. A. Ottenheijm, L. M. Heunks, G. C. Sieck, W. Z. Zhan, S. M. Jansen et al., Diaphragm dysfunction in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.172, pp.200-205, 2005.

T. Troosters, R. Gosselink, W. Janssens, and M. Decramer, Exercise training and pulmonary rehabilitation: new insights and remaining challenges, Eur Respir Rev, vol.19, pp.24-29, 2010.

I. Vivodtzev, P. Gagnon, V. Pepin, D. Saey, L. Laviolette et al., Physiological correlates of endurance time variability during constant-workrate cycling exercise in patients with COPD, PLoS ONE, vol.6, p.17007, 2011.

M. J. Mador, O. Deniz, A. Aggarwal, and T. J. Kufel, Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.168, pp.102-108, 2003.

D. Saey and T. Troosters, Measuring skeletal muscle strength and endurance, from bench to bedside, Clin Invest Med, vol.31, pp.307-311, 2008.

M. Cifrek, V. Medved, S. Tonkovi?, and S. Ostoji?, Surface EMG based muscle fatigue evaluation in biomechanics, Clin Biomech (Bristol, Avon), vol.24, pp.327-340, 2009.

R. R. Rondelli, S. Dal-corso, A. Simões, and C. Malaguti, Methods for the assessment of peripheral muscle fatigue and its energy and metabolic determinants in COPD, J Bras Pneumol, vol.35, pp.1125-1135, 2009.

C. Malaguti, L. E. Nery, D. Corso, S. Nápolis, L. et al., Scaling skeletal muscle function to mass in patients with moderate-to-severe COPD, Eur J Appl Physiol, vol.98, pp.482-488, 2006.

A. Ramirez-sarmiento, M. Orozco-levi, R. Guell, E. Barreiro, N. Hernandez et al., Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes, Am J Respir Crit Care Med, vol.166, pp.1491-1497, 2002.

R. Boushel, H. Langberg, J. Olesen, J. Gonzales-alonzo, J. Bülow et al., Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease, Scand J Med Sci Sports, vol.11, pp.213-222, 2001.

D. C. Berton, P. B. Barbosa, L. S. Takara, G. R. Chiappa, A. C. Siqueira et al., Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD, Thorax, vol.65, pp.588-593, 2010.

A. Borghi-silva, C. C. Oliveira, C. Carrascosa, J. Maia, D. C. Berton et al., Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPD, Thorax, vol.63, pp.910-915, 2008.

I. Vogiatzis, D. Athanasopoulos, G. Stratakos, C. Garagouni, A. Koutsoukou et al., Exerciseinduced skeletal muscle deoxygenation in O-supplemented COPD patients, Scand J Med Sci Sports, vol.19, pp.364-372, 2009.

A. C. Siqueira, A. Borghi-silva, D. M. Bravo, E. M. Ferreira, G. R. Chiappa et al., Effects of hyperoxia on the dynamics of skeletal muscle oxygenation at the onset of heavy-intensity exercise in patients with COPD, Respir Physiol Neurobiol, vol.172, pp.8-14, 2010.

Z. Louvaris, S. Zakynthinos, A. Aliverti, H. Habazettl, M. Vasilopoulou et al., Heliox increases quadriceps muscle oxygen delivery during exercise in COPD patients with and without dynamic hyperinflation, J Appl Physiol, vol.113, pp.1012-1023, 1985.

P. Lévy, B. Wuyam, J. L. Pépin, H. Reutenauer, and J. F. Payen, Skeletal muscle abnormalities in chronic obstructive lung disease with respiratory insufficiency. Value of P31 magnetic resonance spectroscopy

, Rev Mal Respir, vol.14, pp.183-191, 1997.

M. A. Spruit, R. Gosselink, T. Troosters, K. De-paepe, and M. Decramer, Resistance versus endurance training in patients with COPD and peripheral muscle weakness, Eur Respir J, vol.19, pp.1072-1078, 2002.

S. Bernard, F. Whittom, P. Leblanc, J. Jobin, R. Belleau et al., Aerobic and strength training in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.159, pp.896-901, 1999.

D. E. O'donnell, M. Mcguire, L. Samis, and K. A. Webb, General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation, Am J Respir Crit Care Med, vol.157, pp.1489-1497, 1998.

F. Ortega, J. Toral, P. Cejudo, R. Villagomez, H. Sánchez et al., Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.166, pp.669-674, 2002.

T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer, Pulmonary rehabilitation in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.172, pp.19-38, 2005.

M. K. Beauchamp, T. Janaudis-ferreira, R. S. Goldstein, and D. Brooks, Optimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease -a systematic review, Chron Respir Dis, vol.8, pp.129-140, 2011.

M. K. Beauchamp, M. Nonoyama, R. S. Goldstein, K. Hill, T. E. Dolmage et al., Interval versus continuous training in individuals with chronic obstructive pulmonary disease-a systematic review, Thorax, vol.65, pp.157-164, 2010.

T. E. Dolmage and R. S. Goldstein, Response to one-legged cycling in patients with COPD, Chest, vol.129, pp.325-332, 2006.

T. E. Dolmage and R. S. Goldstein, Effects of one-legged exercise training of patients with COPD, Chest, vol.133, pp.370-376, 2008.

I. Vogiatzis, G. Terzis, S. Nanas, G. Stratakos, D. C. Simoes et al., Skeletal muscle adaptations to interval training in patients with advanced COPD, Chest, vol.128, pp.3838-3845, 2005.

I. Vogiatzis, G. Stratakos, D. C. Simoes, G. Terzis, O. Georgiadou et al., Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD, Thorax, vol.62, pp.950-956, 2007.

F. Maltais, P. Leblanc, C. Simard, J. Jobin, C. Bérubé et al., Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.154, pp.442-447, 1996.

T. Troosters, R. Gosselink, and M. Decramer, Exercise training in COPD: how to distinguish responders from nonresponders, J Cardiopulm Rehabil, vol.21, pp.10-17, 2001.

C. Bouchard, M. A. Sarzynski, T. K. Rice, W. E. Kraus, T. S. Church et al., Genomic predictors of the maximal O 2 uptake response to standardized exercise training programs, J Appl Physiol, vol.110, pp.1160-1170, 1985.

F. Pitta, T. Troosters, V. S. Probst, D. Langer, M. Decramer et al., Are patients with COPD more active after pulmonary rehabilitation?, Chest, vol.134, pp.273-280, 2008.

S. Radom-aizik, N. Kaminski, S. Hayek, H. Halkin, D. M. Cooper et al., Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease, J Appl Physiol, vol.102, pp.1976-1984, 1985.

F. Gouzi, C. Préfaut, A. Abdellaoui, E. Roudier, P. De-rigal et al., Blunted muscle angiogenic training-response in COPD patients versus sedentary controls, Eur Respir J, vol.41, pp.806-814, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01624893

D. Constantin, M. K. Menon, L. Houchen-wolloff, M. D. Morgan, S. J. Singh et al., Skeletal muscle molecular responses to resistance training and dietary supplementation in COPD, Thorax, vol.68, pp.625-633, 2013.

R. A. Rabinovich, E. Ardite, A. M. Mayer, M. F. Polo, J. Vilaró et al., Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index, Respiration, vol.73, pp.757-761, 2006.

E. M. Mercken, G. J. Hageman, A. M. Schols, M. A. Akkermans, A. Bast et al., Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.172, pp.994-1001, 2005.

E. M. Mercken, G. J. Hageman, R. C. Langen, E. F. Wouters, and A. M. Schols, Decreased exercise-induced expression of nuclear factor-kBregulated genes in muscle of patients with COPD, Chest, vol.139, pp.337-346, 2011.

S. Pascual-guardia, E. Wodja, A. Gorostiza, E. Lopez-de-santamaria, J. Gea et al., Improvement in quality of life and exercise capacity without muscular biology changes after general training in patients with severe chronic obstructive pulmonary disease

, Med Clin (Barc), vol.140, pp.200-206, 2013.

L. Laviolette, L. C. Lands, N. Dauletbaev, D. Saey, J. Milot et al., Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study, J Med Food, vol.13, pp.589-598, 2010.

M. A. Williams, W. L. Haskell, P. A. Ades, E. A. Amsterdam, V. Bittner et al., Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the, American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation, vol.116, pp.572-584, 2007.

S. D. O'shea, N. F. Taylor, and J. D. Paratz, Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review, Chest, vol.136, pp.1269-1283, 2009.

L. Houchen, M. C. Steiner, and S. J. Singh, How sustainable is strength training in chronic obstructive pulmonary disease?, Physiotherapy, vol.95, pp.1-7, 2009.

C. Burtin, M. Decramer, R. Gosselink, W. Janssens, and T. Troosters, Rehabilitation and acute exacerbations, Eur Respir J, vol.38, pp.702-712, 2011.

M. A. Puhan, A. Spaar, M. Frey, A. Turk, O. Brändli et al., Early versus late pulmonary rehabilitation in chronic obstructive pulmonary disease patients with acute exacerbations: a randomized trial, Respiration, vol.83, pp.499-506, 2012.

M. A. Puhan, E. Gimeno-santos, M. Scharplatz, T. Troosters, E. H. Walters et al., Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.10, p.5305, 2011.

N. Murphy, C. Bell, and R. W. Costello, Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation, Respir Med, vol.99, pp.1297-1302, 2005.

J. M. Seymour, L. Moore, C. J. Jolley, K. Ward, J. Creasey et al., Outpatient pulmonary rehabilitation following acute exacerbations of COPD, Thorax, vol.65, pp.423-428, 2010.

I. Vivodtzev, Y. Lacasse, and F. Maltais, Neuromuscular electrical stimulation of the lower limbs in patients with chronic obstructive pulmonary disease, J Cardiopulm Rehabil Prev, vol.28, pp.79-91, 2008.

M. J. Sillen, C. M. Speksnijder, R. M. Eterman, P. P. Janssen, S. S. Wagers et al., Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature, Chest, vol.136, pp.44-61, 2009.

J. A. Neder, D. Sword, S. A. Ward, E. Mackay, L. M. Cochrane et al., Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD), Thorax, vol.57, pp.333-337, 2002.

A. Abdellaoui, C. Préfaut, F. Gouzi, A. Couillard, M. Coisy-quivy et al., Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study, Eur Respir J, vol.38, pp.781-788, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02398245

S. Dal-corso, L. Nápolis, C. Malaguti, A. C. Gimenes, A. Albuquerque et al., Skeletal muscle structure and function in response to electrical stimulation in moderately impaired COPD patients, Respir Med, vol.101, pp.1236-1243, 2007.

I. Vivodtzev, R. Debigaré, P. Gagnon, V. Mainguy, D. Saey et al., Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial, Chest, vol.141, pp.716-725, 2012.

V. Kim, J. O. Benditt, R. A. Wise, and A. Sharafkhaneh, Oxygen therapy in chronic obstructive pulmonary disease, Proc Am Thorac Soc, vol.5, pp.513-518, 2008.

, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial, Ann Intern Med, vol.93, pp.391-398, 1980.

, Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema, Lancet, vol.1, pp.681-686, 1981.

G. L. Semenza, Oxygen sensing, homeostasis, and disease, N Engl J Med, vol.365, pp.537-547, 2011.

I. Gertz, G. Hedenstierna, G. Hellers, and J. Wahren, Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure, Clin Sci Mol Med, vol.52, pp.396-403, 1977.

P. Jakobsson and L. Jorfeldt, Long-term oxygen therapy may improve skeletal muscle metabolism in advanced chronic obstructive pulmonary disease patients with chronic hypoxaemia, Respir Med, vol.89, pp.471-476, 1995.

D. E. O'donnell, D. 'arsigny, C. Webb, and K. A. , Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.163, pp.892-898, 2001.

F. Maltais, M. Simon, J. Jobin, M. Desmeules, M. J. Sullivan et al., Effects of oxygen on lower limb blood flow and O2 uptake during exercise in COPD, Med Sci Sports Exerc, vol.33, pp.916-922, 2001.

A. Somfay, J. Porszasz, S. M. Lee, and R. Casaburi, Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients, Eur Respir J, vol.18, pp.77-84, 2001.

J. Porszasz, M. Emtner, S. Goto, A. Somfay, B. J. Whipp et al., Exercise training decreases ventilatory requirements and exerciseinduced hyperinflation at submaximal intensities in patients with COPD, Chest, vol.128, pp.2025-2034, 2005.

M. Emtner, J. Porszasz, M. Burns, A. Somfay, and R. Casaburi, Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients, Am J Respir Crit Care Med, vol.168, pp.1034-1042, 2003.

M. L. Nonoyama, D. Brooks, Y. Lacasse, G. H. Guyatt, and R. S. Goldstein, Oxygen therapy during exercise training in chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.2, p.5372, 2007.

M. A. Vermeeren, E. C. Creutzberg, A. M. Schols, D. S. Postma, W. R. Pieters et al., Prevalence of nutritional depletion in a large out-patient population of patients with COPD, Respir Med, vol.100, pp.1349-1355, 2006.

M. P. Engelen, A. M. Schols, W. C. Baken, G. J. Wesseling, and E. F. Wouters, Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD, Eur Respir J, vol.7, pp.1793-1797, 1994.

L. Yang, M. Zhou, M. Smith, G. Yang, R. Peto et al., Body mass index and chronic obstructive pulmonary disease-related mortality: a nationally representative prospective study of 220,000 men in China, Int J Epidemiol, vol.39, pp.1027-1036, 2010.

J. Sundh, B. Ställberg, K. Lisspers, S. M. Montgomery, and C. Janson, Comorbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire, COPD, vol.8, pp.173-181, 2011.

H. Katsura, K. Yamada, and K. Kida, Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD, Respir Med, vol.99, pp.624-630, 2005.

R. De-marco, S. Accordini, A. Marcon, I. Cerveri, J. M. Antó et al., Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults, Am J Respir Crit Care Med, vol.183, pp.891-897, 2011.

C. E. Weekes, P. W. Emery, and M. Elia, Dietary counselling and food fortification in stable COPD: a randomised trial, Thorax, vol.64, pp.326-331, 2009.

M. C. Steiner, R. L. Barton, S. J. Singh, and M. D. Morgan, Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial, Thorax, vol.58, pp.745-751, 2003.

J. Efthimiou, J. Fleming, C. Gomes, and S. G. Spiro, The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease, Am Rev Respir Dis, vol.137, pp.1075-1082, 1988.

E. C. Creutzberg, E. F. Wouters, R. Mostert, C. A. Weling-scheepers, and A. M. Schols, Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease, Nutrition, vol.19, pp.120-127, 2003.

C. M. Op-den-kamp, R. C. Langen, A. Haegens, and A. M. Schols, Muscle atrophy in cachexia: can dietary protein tip the balance?, Curr Opin Clin Nutr Metab Care, vol.12, pp.611-616, 2009.

S. Baldi, R. Aquilani, G. D. Pinna, P. Poggi, D. Martini et al., Fatfree mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia, Int J Chron Obstruct Pulmon Dis, vol.5, pp.29-39, 2010.

M. P. Engelen, E. P. Rutten, D. Castro, C. L. Wouters, E. F. Schols et al., Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease, Am J Clin Nutr, vol.85, pp.431-439, 2007.

C. M. Pison, N. J. Cano, C. Chérion, F. Caron, I. Court-fortune et al., Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial, IRAD Investigators, vol.66, pp.953-960, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00696275

E. C. Creutzberg, A. M. Schols, C. A. Weling-scheepers, W. A. Buurman, and E. F. Wouters, Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.161, pp.745-752, 2000.

K. Sugawara, H. Takahashi, C. Kasai, N. Kiyokawa, T. Watanabe et al., Effects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPD, Respir Med, vol.104, pp.1883-1889, 2010.

K. Sugawara, H. Takahashi, T. Kashiwagura, K. Yamada, S. Yanagida et al., Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD, Respir Med, vol.106, pp.1526-1534, 2012.

R. Broekhuizen, E. F. Wouters, E. C. Creutzberg, C. A. Weling-scheepers, and A. M. Schols, Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease, Thorax, vol.60, pp.376-382, 2005.

C. Van-de-bool, M. C. Steiner, and A. M. Schols, Nutritional targets to enhance exercise performance in chronic obstructive pulmonary disease, Curr Opin Clin Nutr Metab Care, vol.15, pp.553-560, 2012.

E. P. Rutten, M. P. Engelen, H. Gosker, A. Bast, K. Cosemans et al., Metabolic and functional effects of glutamate intake in patients with chronic obstructive pulmonary disease (COPD), Clin Nutr, vol.27, pp.408-415, 2008.

S. Marwood, S. Jack, M. Patel, P. Walker, J. Bowtell et al., No effect of glutamine ingestion on indices of oxidative metabolism in stable COPD, Respir Physiol Neurobiol, vol.177, pp.41-46, 2011.

H. Saudny-unterberger, J. G. Martin, and K. Gray-donald, Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.156, pp.794-799, 1997.

C. R. Van-wetering, M. Hoogendoorn, R. Broekhuizen, G. J. Geraerts-keeris, D. Munck et al., Efficacy and costs of nutritional rehabilitation in musclewasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial, J Am Med Dir Assoc, vol.11, pp.179-187, 2010.

S. Bhasin and R. Jasuja, Selective androgen receptor modulators as function promoting therapies, Curr Opin Clin Nutr Metab Care, vol.12, pp.232-240, 2009.

J. T. Dalton, K. G. Barnette, C. E. Bohl, M. L. Hancock, D. Rodriguez et al., The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebocontrolled phase II trial, J Cachexia Sarcopenia Muscle, vol.2, pp.153-161, 2011.

S. Bhasin, L. Woodhouse, R. Casaburi, A. B. Singh, D. Bhasin et al., Testosterone dose-response relationships in healthy young men, Am J Physiol Endocrinol Metab, vol.281, pp.1172-1181, 2001.

S. Bhasin, L. Woodhouse, R. Casaburi, A. B. Singh, R. P. Mac et al., Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle, J Clin Endocrinol Metab, vol.90, pp.678-688, 2005.

A. S. Dobs, T. Nguyen, C. Pace, and C. P. Roberts, Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women, J Clin Endocrinol Metab, vol.87, pp.1509-1516, 2002.

J. Svartberg, U. Aasebø, A. Hjalmarsen, J. Sundsfjord, and R. Jorde, Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial, Respir Med, vol.98, pp.906-913, 2004.

A. M. Schols, P. B. Soeters, R. Mostert, R. J. Pluymers, and E. F. Wouters, Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebocontrolled randomized trial, Am J Respir Crit Care Med, vol.152, pp.1268-1274, 1995.

I. M. Ferreira, I. T. Verreschi, L. E. Nery, R. S. Goldstein, N. Zamel et al., The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients, Chest, vol.114, pp.19-28, 1998.

S. S. Yeh, B. Deguzman, T. Kramer, and . Group, Reversal of COPD-associated weight loss using the anabolic agent oxandrolone, Chest, vol.122, pp.421-428, 2002.

R. Casaburi, B. Make, C. Piquette, T. Kramer, and A. Ries, Oxandrolone increases weight and muscle mass in underweight COPD patients, Chest, vol.122, p.73, 2002.

E. C. Creutzberg, E. F. Wouters, R. Mostert, R. J. Pluymers, and A. M. Schols, A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial, Chest, vol.124, pp.1733-1742, 2003.

S. Sharma, A. Arneja, L. Mclean, D. Duerksen, W. Leslie et al., Anabolic steroids in COPD: a review and preliminary results of a randomized trial, Chron Respir Dis, vol.5, pp.169-176, 2008.

B. Chavoshan, M. Fournier, M. I. Lewis, J. Porszasz, T. W. Storer et al., Testosterone and resistance training effects on muscle nitric oxide synthase isoforms in COPD men, Respir Med, vol.106, pp.269-275, 2012.

M. L. Hartman, A. C. Faria, M. L. Vance, M. L. Johnson, M. O. Thorner et al., Temporal structure of in vivo growth hormone secretory events in humans, Am J Physiol, vol.260, pp.101-110, 1991.

A. Giustina and J. D. Veldhuis, Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human, Endocr Rev, vol.19, pp.717-797, 1998.

C. F. Estívariz and T. R. Ziegler, Nutrition and the insulin-like growth factor system, Endocrine, vol.7, pp.65-71, 1997.

H. Liu, D. M. Bravata, I. Olkin, A. Friedlander, V. Liu et al., Systematic review: the effects of growth hormone on athletic performance, Ann Intern Med, vol.148, pp.747-758, 2008.

M. J. Mador and E. Bozkanat, Skeletal muscle dysfunction in chronic obstructive pulmonary disease, Respir Res, vol.2, pp.216-224, 2001.

I. S. Anand, Y. Chandrashekhar, R. Ferrari, R. Sarma, R. Guleria et al., Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery, Circulation, vol.86, pp.12-21, 1992.

S. Scalvini, M. Volterrani, M. Vitacca, A. L. Clark, R. Solfrini et al., Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease, Monaldi Arch Chest Dis, vol.51, pp.380-386, 1996.

E. C. Creutzberg and R. Casaburi, Endocrinological disturbances in chronic obstructive pulmonary disease, Eur Respir J Suppl, vol.46, pp.76-80, 2003.

Z. Zadik, S. A. Chalew, R. J. Mccarter, M. Meistas, and A. A. Kowarski, The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals, J Clin Endocrinol Metab, vol.60, pp.513-516, 1985.

W. B. Wehrenberg, B. A. Janowski, A. W. Piering, F. Culler, and K. L. Jones, Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion, Endocrinology, vol.126, pp.3200-3203, 1990.

J. D. Veldhuis and A. Iranmanesh, Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep, Sleep, vol.19, pp.221-224, 1996.

M. R. Graham, J. S. Baker, P. Evans, A. Kicman, D. Cowan et al., Short-term recombinant human growth hormone administration improves respiratory function in abstinent anabolic-androgenic steroid users, Growth Horm IGF Res, vol.17, pp.328-335, 2007.

U. Meinhardt, A. E. Nelson, J. L. Hansen, V. Birzniece, D. Clifford et al., The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial, Ann Intern Med, vol.152, pp.568-577, 2010.

G. S. Pape, M. Friedman, L. E. Underwood, and D. R. Clemmons, The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease, Chest, vol.99, pp.1495-1500, 1991.

N. P. Gullett, G. Hebbar, and T. R. Ziegler, Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting, Am J Clin Nutr, vol.91, pp.1143-1147, 2010.

L. Burdet, B. De-muralt, Y. Schutz, C. Pichard, and J. W. Fitting, Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study, Am J Respir Crit Care Med, vol.156, pp.1800-1806, 1997.

U. Suchner, M. M. Rothkopf, G. Stanislaus, D. H. Elwyn, V. Kvetan et al., Metabolic effects in patients receiving parenteral nutrition, Arch Intern Med, vol.150, pp.1225-1230, 1990.

O. Khorram, Use of growth hormone and growth hormone secretagogues in aging: help or harm, Clin Obstet Gynecol, vol.44, pp.893-901, 2001.

P. E. Clayton, I. Banerjee, P. G. Murray, and A. G. Renehan, Growth hormone, the insulin-like growth factor axis, insulin and cancer risk, Nat Rev Endocrinol, vol.7, pp.11-24, 2011.

A. W. Root and M. J. Root, Clinical pharmacology of human growth hormone and its secretagogues, Curr Drug Targets Immune Endocr Metabol Disord, vol.2, pp.27-52, 2002.

S. Chappel, Can GHRH or GH secretagogues re-initiate pituitary GH pulsatility?, Clin Endocrinol (Oxf), vol.50, pp.547-556, 1999.

Y. Wang and B. Tomlinson, Tesamorelin, a human growth hormone releasing factor analogue, Expert Opin Investig Drugs, vol.18, pp.303-310, 2009.

M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo et al., Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature, vol.402, pp.656-660, 1999.

R. G. Smith, L. H. Van-der-ploeg, A. D. Howard, S. D. Feighner, K. Cheng et al., Peptidomimetic regulation of growth hormone secretion, Endocr Rev, vol.18, pp.621-645, 1997.

S. Gnanapavan, B. Kola, S. A. Bustin, D. G. Morris, P. Mcgee et al., The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans, J Clin Endocrinol Metab, vol.87, pp.2988-2991, 2002.

A. M. Wren, L. J. Seal, M. A. Cohen, A. E. Brynes, G. S. Frost et al., Ghrelin enhances appetite and increases food intake in humans, J Clin Endocrinol Metab, vol.86, pp.5992-5995, 2001.

R. Granata, J. Isgaard, G. Alloatti, and E. Ghigo, Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone, Exp Biol Med (Maywood), vol.236, pp.505-514, 2011.

M. Tschöp, D. L. Smiley, and M. L. Heiman, Ghrelin induces adiposity in rodents, Nature, vol.407, pp.908-913, 2000.

N. M. Neary, C. J. Small, A. M. Wren, J. L. Lee, M. R. Druce et al., Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial, J Clin Endocrinol Metab, vol.89, pp.2832-2836, 2004.

N. Nagaya, T. Itoh, S. Murakami, H. Oya, M. Uematsu et al., Treatment of cachexia with ghrelin in patients with COPD, Chest, vol.128, pp.1187-1193, 2005.

L. Chopin, C. Walpole, I. Seim, P. Cunningham, R. Murray et al., Ghrelin and cancer, Mol Cell Endocrinol, vol.340, pp.65-69, 2011.

T. Shiiya, M. Nakazato, M. Mizuta, Y. Date, M. S. Mondal et al., Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion, J Clin Endocrinol Metab, vol.87, pp.240-244, 2002.

D. E. Cummings, D. S. Weigle, R. S. Frayo, P. A. Breen, M. K. Ma et al., Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery, N Engl J Med, vol.346, pp.1623-1630, 2002.

B. W. Ying, X. B. Song, H. Fan, L. L. Wang, Y. S. Li et al., Plasma ghrelin levels and weight loss in Chinese Uygur patients with chronic obstructive pulmonary disease, J Int Med Res, vol.36, pp.1371-1377, 2008.

T. Itoh, N. Nagaya, M. Yoshikawa, A. Fukuoka, H. Takenaka et al., Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.170, pp.879-882, 2004.